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Abstract 
 
(1) Development of abasic site-containing DNA duplex-based aptamers for 
theophylline’s detection 1 
Aptamers, short nucleic acids with significant binding ability, have emerged as 
promising candidates for molecular recognition events to various ligands. Our group has 
reported a fluorescent signaling aptamer that targets a common drug, theophylline.
2 
In this 
DNA duplex aptamer, an abasic site (AP site) was utilized as an active cavity for binding 
events (cf. Fig. 1), and a fluorescent adenine analogue, 2-aminopurine, was incorporated into 
the duplex so as to flank the AP site. However, the need of the modification with 
2-aminopurine makes the assay expensive, and the poor photostability of 2-aminopurine is 
also problematic. 
In this work, a modification-free AP site-containing DNA duplex aptamer (AP-aptamer) 
is developed for the detection of theophylline. The assay is based on the competitive binding 
of theophylline with riboflavin at the AP site. As shown in Fig. 1, in the absence of 
theophylline, riboflavin binds to the receptor nucleobase opposite the AP site, and this is 
accompanied by fluorescence quenching. Upon addition of theophylline, the competitive 
binding of theophylline with riboflavin occurs, which results in the effective fluorescence 
restoration due to the release of riboflavin from the AP site. 
 
Fig.1. Competitive binding of theophylline with a fluorescent ligand at an AP site in a DNA duplex 
aptamer.  
 
Riboflavin/23-mer AP aptamer (5’-TCT GCG TCC AGX GCA ACG CAC 
AC-3’/5’-GTG TGC GTT GCC CTG GAC GCA GA-3’; X: the AP site (Spacer C3, a 
propylene residue)) system is found to be effective for the detection of theophylline with a 
high selectivity over caffeine, theobromine and other substrates. In serum samples, a linear 
response to theophylline can be obtained in the concentration range from 10 M to 33 M (50 
M to 163 M in original serum samples), which covers the monitoring of serum 
theophylline concentration in the therapeutic range (60 M to 100 M). This system is thus 
expected to be applicable to practical use. 
 
2 
 
(2) Development of a highly selective ligand binding with cytosine opposite an abasic site 
in DNA duplexes
3 
Detection of single-nucleotide polymorphisms (SNPs) in human genome has become 
increasingly important in the fields of genetics, molecular diagnostics and cancer research. 
Our group has reported that a naphthyridine derivative (AMND, Fig. 2)
4
 was capable of  
selectively binding to cytosine (C) opposite an AP-site in DNA duplexes, and the 
binding-induced fluorescence quenching was applicable to the analysis of the C- related 
single base mutation. However, AMND showed an insufficient selectivity for C/T 
discrimination: the difference in the binding affinity of AMND for C over T is only two- or 
three-fold.
3,4 
 
Fig.2. Binding modes of AMND/CF3-AMND with C and T (2 possible patterns). 
 
In this work, AMND is modified for highly selective detection of C by introducing of 
CF3 group to the naphthyridine ring. The binding constant of the resulting CF3-AMND (Fig. 
2) for C (K11/10
5
 M
−1
 (n = 3): 7.1 ± 0.2) is found to be more than 50-fold larger than those for 
the other three nucleobases (K11/10
5
 M
−1
 (n = 3): T, 0.14 ± 0.016; G, 0.16 ± 0.029; A, <0.10). 
The high selectivity might be caused from more favorable protonation at the N1 position than 
the N8 position due to the electron-withdrawing effect of the CF3 group, which then enables 
the effective pseudo-base pairing with C through hydrogen bonding (Fig. 2). Furthermore, 
CF3-AMND is applicable to the analysis of single-base mutation in 107-mer DNAs (K-ras 
gene; codon 12, sense strand) amplified by asymmetric PCR, with highly selectivity for C. 
This will facilitate the accurate analysis of C-related single-base mutation in practical use. 
 
 
(3) Development of peptide nucleic acid-thiazole orange conjugates for discrimination of 
terminal mismatches in DNA/RNA 
In general, detection of mismatches of DNA/RNAs relies on the method based on the 
thermal stability of duplex hybridization. A mismatch near or at the terminus of a duplex is 
less destabilized than an internal mismatch, so as to be difficult for terminal mismatch 
detection. Recently, our group has developed a peptide nucleic acid conjugated with thiazole 
orange (PNA-TO) for siRNA imaging in living cells.
5
 This ligand was capable of binding to 
3’-overhanging nucleotides with a good selectivity for perfect match sequences over other 
3 
 
mismatched ones. For the binding of this ligand, PNA unit recognizes the terminal two 
nucleobases via complementary hydrogen-bonding, and TO unit works as a fluorescent probe 
by intercalation into the duplex (cf. Fig.3).  
                                    
Fig.3. (A) Illustration of PNA-TO binding to terminal nucleobases; 
(B) Structures of representative PNA-TO ligands (C6 and Py-C4). 
 
    In this work, PNA-TO conjugates are developed for the detection of a single nucleobase 
mismatch at the terminal positions of DNA/RNAs (Fig. 3). All of the synthesized PNA-TO 
conjugates show a good selectivity at 3’ end, but the selectivity is moderate for terminal 
mismatches at 5’ end. To improve the binding selectivity at 5’ end, pyrene as a -stacking cap 
has been introduced into the N-terminal of PNA-TO. The resulting Pyrene-PNA-TO shows a 
specific binding ability for perfect match over terminal mismatches, including the most 
disturbing position, the very 1
st
 terminal mismatch. In addition, Pyrene-PNA-TO is applicable 
to microRNA detection to recognize let-7d out of let-7 family with LOD as low as 0.9 nmol in 
50 L sample. It’s thus expected that our method is promising for terminal mismatch 
detection and the ligand design would have flexibility for any kind of terminal sequences. 
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Chapter 1: General introduction 
 
1-1. Introduction 
As we known, nucleic acids—DNA/RNAs are genetic material and play a crucial role in 
coding, decoding, regulation, and expression of genes. Thus, DNA/RNAs become a 
long-standing target for the diagnosis and treatment for multitude of human diseases. 
Small ligands, which are capable of interacting with DNA/RNA sequences, become 
powerful tools in many kinds of fields. For example, Neomycin B which can bind to HIV-1 
TAR RNA is typical of such ligands for drug development.
1
 
As another one of those useful fields, oligo-DNA/RNAs can be the targets to be 
recognized by stain ligands in developing analytical methods, or as aptamers for specific 
small ligand-recognitions. 
In this thesis, I will show three applications all based on utilizing DNA/RNA-small 
ligand interactions. In chapter 2, a modification-free AP-aptamer for the detection of 
theophylline has been developed. In chapter 3, a specific binding ligand for cytosine opposite 
an AP-site in DNA duplexes has been developed, which is applicable in C- related single base 
mutation. And in chapter 4, a series of PNA-TO conjugates for the terminal mismatch 
detection of DNA/RNAs has been achieved. 
 
 
1-2. Typical binding modes of small ligands toward DNA/RNAs 
According to the binding happened positions, the binding modes of small ligands toward 
DNA/RNAs can be divided into intercalation, groove binding, internal- or bulge- or hairpin- 
loop binding, backbone binding, and capping (Figure 1-1).
2,3
 Ethidium bromide
4
 
(intercalation) and Hoechst 33258
5 
(minor groove binding) are typical of such ligands. 
 
Figure 1-1. Binding modes of small ligands interacting with nucleic acid duplexes. 
    In our group, abasic site (AP site) as the binding site has been paid attention to for 
5 
 
detecting the nucleobase genotype, mainly because of its chemical stability (ref. section 
2-1-5). Designed small ligands are able to bind at an AP site and recognize the specific 
nucleobase opposite the AP site with high affinity and specificity. This is generally achieved 
by a combination of molecular shape complementarity, hydrogen-bonding and stacking 
interactions. Such binding events typically involve the ligand-induced structural changes of 
the aptamers, resulting in the formation of unique secondary and tertiary structures 
responsible to the ligand binding. (ref. Chapter 2) 
 
1-3. Differences of structure between DNA and RNA duplexes 
DNA and RNA are both nucleic acids, which are similar but not exactly the same.  
Biologically, almost all of life use DNA as its genetic code. Only when there is a mistake 
happened during the duplication period, DNA-cleavage enzymes will generate, thus this 
makes the information stored by DNA consistent. However, RNA’s main duty is assist DNA’s 
duplication. So RNA strands are continually made, broken down, and reused. It requires the 
energy of cleaving RNA not be too high. For the three-dimensional structure, the double 
stranded DNA has relatively small grooves as opposed to the larger grooves on RNA 
molecules. This provides ample docking space of RNA for damaging enzymes. 
Structurally, DNA contains deoxyribose, while RNA contains ribose. The deoxyribose 
sugar in DNA is less reactive than the ribose sugar for there is no hydroxyl group attached to 
the pentose ring in the 2’ position. However, RNA has hydroxyl groups, which make RNA 
less stable for its more prone to hydrolysis.
6
 
Importantly, DNA and RNA’s secondary structure (the base-pairing interactions) and 
tertiary structure (three-dimensional structure) are different. As we all know, the 
complementary base to adenine (A) is thymine (T) in DNA, but uracil (U) in RNA, which is 
an unmethylated form of thymine. In addition, the double helix structure of DNA is general 
slim B-form; while it’s compact A-form for RNA (Figure 1-2 and Table 1-1). This formation 
difference results the difference for small ligands’ binding. For example, compared to 
B-formed DNA, the overlap of a small ligand with the adjacent nucleobases are more feasible 
in A-formed RNA structure, which can make stacking interactions stronger for the ligand.
7
  
 
Figure 1-2. Tertiary structures of DNA duplex, DNA/RNA hybrid, and RNA duplex. 
6 
 
 
Geometry attribute: B-form A-form 
Helix sense right-handed right-handed 
Rotation/bp 35.9° 33.6° 
Mean bp/turn 10.5 11 
Rise/bp along axis 3.4 Å 2.4 Å  
Rise/turn of helix 33.2 Å 24.6 Å 
Mean propeller twist +16° +18° 
Nucleotide phosphate to 
phosphate distance 
7.0 Å 5.9 Å 
Sugar pucker C2’-endo C3’-endo 
Diameter 20 Å 23 Å 
Table 1-1. Comparison of B-form and A-form nucleic acid structures.
8
 
 
Since those differences between DNA and RNA duplexes, although some small ligands 
designed for DNA or RNA could have the universal to the other kind of nucleic acid, it’s not 
always workable. In another word, the ability for designed ligands to bind with DNA is not 
always maintained to RNA, and vise versa. 
In chapter 2, considered the similarity, DNA aptamer was utilized because it is more 
stable and economic than corresponding RNA aptamers (ref. section 2-1-2-4). In chapter 4, 
our final application showed a microRNA assay, although DNAs were utilized for the 
preliminary experiments for the same reason. In that application, we successfully achieved 
our goal by using RNAs based on the preliminary experiments by DNAs. Still, I have to point 
out that we should always keep in mind that DNA and RNA are different, and the ligands 
which can bind to a DNA strand, could be not able to simply transfer to the corresponding 
RNA. 
 
References 
1. Sucheck, S. J., Wong, C.-H., Curr. Opin. Chem. Biol., 2000, 4, 678-686. 
2. Ananya Paul, and Santanu Bhattacharya, Current Science, 2012, 102(2), 212-231. 
3. Jason R. Thomas and Paul J. Hergenrother, Chemical Reviews, 2008, 108(4), 1171-1224. 
4. Ren J, Jenkins TC, Chaires JB., Biochemistry, 2000, 39, 8439. 
5. Haq I, Ladbury JE, Chowdhry BZ, Jenkins TC, Chaires JB., J. Mol. Biol, 1997, 271, 244. 
6. http://en.wikipedia.org/wiki/RNA 
7. S. Arnott, R. Chandrasekaran, D.W.L. Hukins, P.J.C. Smith, and L. Watts, J. Mol. Biol, 
1974, 88, 523-533. 
8. http://en.wikipedia.org/wiki/A-DNA 
7 
 
Chapter 2: Development of abasic site-containing DNA duplex-based aptamers 
for theophylline’s detection9 
 
2-1. Introduction 
2-1-1. Theophylline 
2-1-1-1. Introduction 
Theophylline, also known as dimethylxanthine, is one of the 
most commonly used drug as bronchodilators and respiratory 
stimulators for the treatment of the symptoms of acute and chronic 
asthmatic conditions.
10-12
 The therapeutic range for theophylline in 
serum is very narrow, and a steady-state concentration is within the 
range of 60-100 M.12 If overdose of theophylline would lead to 
lethal or permanent neurological damage.
12,13
 For this reason, accurate and careful monitoring 
of theophylline concentration in serum becomes indispensable to effective treatments.  
Theophylline is naturally found in tea and cocoa beans. As a member of the xanthine 
(3,7-dihydro-purine-2,6-dione) family, it bears structural and pharmacological similarity to 
caffeine and theobromine. Therefore, in order to get a specific signal for theophylline, 
discrimination from the latter molecules becomes necessary during the monitoring process.  
N
N N
N
O
O
CH3
R2 1
3
6
7
9
R1
Theophylline: R1 = H, R2 = CH3
Caffeine: R1 = CH3, R2 = CH3
Theobromine: R1 = CH3, R2 = H  
Figure 2-1. Structures of methylxanthine compounds: theophylline, caffeine, and theobromine. 
 
 
 
N
N N
H
N
O
O
CH3
Theophylline
H3C
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2-1-1-2. Existence methods for theophylline detection 
Currently, there are mainly two routine methods in the clinical laboratories, which are 
based on gas/liquid chromatographic and immunoassay techniques.
10,11
 However, these 
techniques show relatively low selectivity for theophylline over structurally similar caffeine 
and theobromine. In order to solve these problems, the chromatographic techniques combined 
with the gradient elution
14
 and column switching
15
 have been developed. However, these 
chromatographic techniques still require time-consuming pretreatments such as solvent 
extraction and protein precipitation.
16,17
 On the other hand, the immunoassay with the 
increased selectivity using the theophylline-oxidizing enzyme was reported,
18-21
 but restricted 
availability and low stability of the theophylline-oxidizing enzyme limit the practical use of 
such enzyme.
22
 
In 1994, Jenison et al. developed a RNA aptamer
23
 with high binding affinity to 
theophylline and high discriminative ability against caffeine, which can be considered as a 
new emerging detection method for theophylline. Since then, more and more new aptamers 
were broached out based on electrochemical,
24-26
 fluorescent,
27-29
 and colorimetric
30 
techniques.  
However, one of the main problems with aptamer applicability is the stability and 
proneness to nuclease attack particularly with reference to RNA rather than DNA aptamers.
31
 
In another word, RNA is known to be susceptible to degradation by the endogenous 
ribonucleases typically found in serum. Therefore, it is desirable to establish a detection 
method based on DNAs with high chemical and/or enzymatic stability. 
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2-1-2. Aptamer 
2-1-2-1. Background 
Aptamers are artificial short nucleic acid species with high affinity and selectivity that 
can bind to a wide range of nonnucleic acid targets, such as metal cations, drugs, peptides, 
organic and inorganic molecules, proteins, or even whole cells.
32-44
 The name “aptamer” is 
derived from the Latin aptus, meaning “to fit”. 45 
Aptamers were first reported in 1990 by two groups (Ellington and Szostak; Tuerk and 
Gold)
46,47
. They generated aptamers by an in vitro selection process called SELEX 
(systematic evolution of ligands by exponential enrichment). Since then, the SELEX method 
has been widely used to develop aptamers targeting various molecules. In simple terms, 
SELEX is a method that permits the identification of unique DNA/RNA molecules, which 
bind to the target molecule with high affinity and specificity, from very large populations of 
random sequence oligomers (DNA or RNA libraries).
48
 
As mentioned above, aptamers have a very high affinity for targets, with dissociation 
constants generally from the micromolar to picomolar range, which are comparable to those 
of antibodies, sometimes even better.
23,48
 Aptamers also have a good selectivity for the targets 
over other disturbing molecules. For example, the anti-theophylline aptamer showed a 
10,000-fold discrimination ability against caffeine
23
, and an anti-l-arginine RNA aptamer 
showed a 12,000-fold affinity reduction toward d-arginine
49
. 
Since the discovery of aptamers, many researchers have used aptamer selection as a 
means for application and discovery. More recently, aptamers have been served as research 
tools in molecular recognition of analysis, diagnosis and therapy. 
 
 
2-1-2-2. SELEX process 
SELEX (systematic evolution of ligands by exponential enrichment) has proven to be an 
excellent tool for searching oligonucleotide molecules out of a random pool, with high 
affinity for a particular target under specific conditions. It involves the following processes, 
separately: synthesis and selection of ligand sequences that bind to a target; partitioning of 
aptamers from non-aptamers via affinity methods; and amplification of bound aptamers.  
In the SELEX process (Figure 2-2), synthesis of single-stranded library 
oligonucleotides begins first. Each oligonucleotide comprises a random sequence region in 
the center part and defined region from the 5’ and 3’ ends. Each member of the library is a 
10 
 
linear oligomer with a unique sequence. A large number of random sequences in the library 
are necessary to provide a complexity, and so as to a high possibility to select out useful 
aptamers for certain targets. Typically, the initial circle contains about 10
15
 individual 
sequences
48
, which is a fine number for selection. 
First, the random single-stranded DNA pool is amplified by the polymerase chain 
reaction (PCR) to form a double-strand DNA (dsDNA) pool. And the dsDNA pool is further 
transcribed (for RNA selection) or separated into single strand (for single-stranded DNA 
selection, using the T7 RNA polymerase) to become a suitable form for further selection. 
Second, the library is incubated with the target and the first cycle of absorption is 
initiated. The target can be immobilized (e.g. on magnetic beads, affinity column, microtitre 
plates
50,51
) or free in solution. After incubation, the partition of the DNA/RNA aptamer-target 
complex from non-aptamers is necessary by washing steps. In this way, the non-aptamers 
(non-specific or low affinity for the target) will be removed.  
Then, the bound species are regenerated by enzymatic amplification processes (Reverse 
Transcription-PCR for RNA libraries, or PCR for DNA libraries) for the next selection 
cycle.
52
 The whole cycle is repeated until obtaining a specific population of RNA/DNA, and 
finally is isolated and characterized. To complete entire selection process, 12 cycles are 
usually required, after that the selected molecules can be cloned into an appropriate vector 
and sequenced.
52
 
 
 
Figure 2-2. Scheme of the in vitro selection of an RNA aptamer (SELEX process).
48
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2-1-2-3. Advantages of aptamers (comparison with antibody) 
Besides the high binding affinity and specificity to target, aptamers also have other 
merits including but not limited to the following points. 
 
1) Little or no immunogenicity 
To compare with antibodies, the main advantage of aptamers is overcoming of the 
animal’s use for their production. Typically, antibody production comes from biological 
systems by inducing an immune response to the target analyte. However, the immune 
response can be failed when the structure of target protein is similar to endogenous proteins, 
and when the antigen consists of toxic compounds. In addition, the in vivo parameters restrict 
the identification of antibodies to targets.  
On the contrary, aptamers are selected by in vitro process against any kind of target, 
including proteins and toxic compounds.
48
 
 
2) Various target region at different binding conditions 
The generation process of antibodies is taken out in vivo, which leads to the restriction 
of biological environment. Such as, the animal immune system can only select the specific 
sites of the target protein to which the antibodies bind. And the recognition of antibodies to 
their targets only happens under physiological conditions, which limits the extension use of 
antibodies.
48
 
However, aptamers are able to be generated to bind a certain region of the target (not 
refrained from the immuno effect), and with specific binding ability in different binding 
conditions (temperature, pH, buffer, etc.).
31,48
 
 
3) Stability and ability of regeneration 
Antibodies could hardly avoid the batch-to-batch variation, while aptamers are produced 
and purified to a very high degree to eliminate the variation by chemical synthesis. And 
chemical modifications in the aptamer can be introduced enhancing the stability, affinity and 
specificity of the molecules.  
Because of aptamers’ simple structure, sensor layers based on aptamers can be 
regenerated more easily than antibody-based layers. Aptamers are more resistant to 
denaturation and have a much longer shelf life.
48 
 
4) Enrichment and amplification 
The selections process of aptamers contains amplification step, which is advantageous 
for enrichment. 
 
12 
 
 
Table 1-1. List of aptamers’ advantages.
31 
 
 
2-1-2-4. Limitations of RNA aptamers (comparison of RNA and DNA aptamers) 
The primary limitation of RNA aptamers is their nuclease sensitivity which is very 
critical for the use in ex-vivo and in vivo applications.
53
  
Besides of the low chemical and enzymatic stability, the synthesis costs of RNA 
aptamers are much higher than DNAs. For example, one tube of the 11-mer DNA single 
strand containing dSpacer, which was used in our preliminary experiment, costs 9,975 yen. 
While the same sequence of RNA single strand at a similar Optical Density (O.D.) unit, costs 
111,888 yen, which is over 10 times of the DNA’s cost. 
Generally speaking, DNA aptamers have all the characters of RNA aptamers. They can 
form the secondary and tertiary structures suitable for the effective binding of targets. 
Meanwhile, DNA aptamers are more stable in vivo conditions and cheaper to achieve. 
Therefore, DNA aptamers are more preferable than RNA aptamers. 
 
 
2-1-2-5. Fluorescent sensing aptamers 
As mentioned in the section 2-1-1-2, aptamers can be applied by using electrochemical, 
fluorescent, and colorimetric techniques. Here we only summarized the aptamer types based 
on fluorescent technique. This is because fluorescence signals can be measured conveniently 
with high sensitivity and so have been widely used. 
 
2-1-2-5-1. Introduction 
Aptamers, which bind nonnucleic acid analytes, act as three-dimensional bioreceptors. 
They can form various secondary or tertiary structures with an internal- or stem-loop as the 
active sites. The binding is generally achieved by a combination of molecular shape 
complementary, hydrogen bonding and stacking interactions.  
13 
 
As same as other nucleic acids, aptamers are inherently non-fluorescent, and therefore 
extra modifications with fluorophores must be performed to convert aptamers into 
fluorescence-signaling molecules. As schematically shown in Figure 2-3, an aptamer plays as 
a sensing element here. When target binds to it, the adoption will generate a transduction 
fluorescence signal and this signal can be detected by spectrofluorometers. In this process, the 
fluorophore’s property should obviously have some changes when the aptamer binds to the 
target analyte. In addition, a rational design of aptamer should also consider the following 
aspects, which are photo stability, pH-dependence, the nature and length of aptamer, position 
of the fluorophore attachment (internal or end modification), etc.
54 
 
  
Figure 2-3. Schematic layout of a fluorescent recognition process.
54
 
 
 
2-1-2-5-2. Typical design strategies of aptamer 
The strategies for designing aptamer can be divided into two groups based on the 
attached fluorophores and quenchers on aptamer. One group makes aptamer labeled with one 
single fluorophore, and the other affords aptamer labeled with a pair of fluorophore and 
quencher, or two fluorophores. 
For the first group, the binding to target makes aptamer undergoes a conformational 
change, and this change gives a fluorescence signal (Figure 2-4).
55
 Also, the location of 
fluorophore is important for an effective fluorescence signaling, which has been shown in the 
report of Jhaveri’s group in 2000.35 
 
Figure 2-4. Design strategy for aptamer with one single fluorophore.
55 
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For the second group, there are several mechanisms for the fluorescence detection. 
(Figure 2-6) Probes containing two dyes that cause the transduction processes from binding 
to signaling may rely on: 1) fluorescence quenching (static or dynamic mechanisms); 2) 
fluorescence resonance energy transfer (FRET); and 3) monomer-excimer emission switching 
with pyrene fluorophores.
55
 The third type is out of our concern so is not described in this 
introduction here. 
 
Some proper nouns: 
Molecular Beacon (MB): MB has a hairpin structure with fluorophore and quencher 
probes at 5’ and 3’ terminal, respectively, but close to each other. At this time, the 
fluorescence quenching occurs between the fluorophore and the quencher. However, when 
the target analyte binds to MB, the hairpin conformation of MB will be opened. And as a 
result, the fluorophore and the quencher will be separated from each other with emitting of a 
fluorescence signaling. (Figure 2-6a) 
 
Fluorescence resonance energy transfer (FRET): In a typical FRET system, a 
biopolymer is labeled with two different fluorophores (a donor and an acceptor) at different 
positions. The excitation energy of donor molecule will be transferred to the receptor in a 
nonradiative way because of the interactions between the excited states of these fluorophores. 
After that, the acceptor molecule emits a fluorescence signal.  
The distance between the donor and acceptor fluorophores should be close (typically 
10-80 Å), and the spectra of donor’s emission and acceptor’s absorption should have an 
overlap.
54
(Figure 2-5)  
 
 
Figure 2-5. Example of FRET between CFP and YFP (two dyes; Wavelength vs. Absorption).
56
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In Figure 2-6a, it shows an MB structure with a fluorophore and a quencher at the 5’ 
and 3’ ends, respectively. And the stem-loop region will be responsible for the binding with 
target molecule. In the absence of target, there is only fluorescence quenching signal. Upon 
addition of target, the hairpin structure will be destroyed and caused a change in the distance 
between the fluorophore and the quencher, resulting in a fluorescent enhancement signal. 
Hamaguchi et al. reported this type molecular-beacon approach for thrombin.
57
 
In Figure 2-6b, a simpler aptamer is shown, which is attached by a fluorophore and a 
quencher at two ends without a stem-loop structure. High fluorescence intensity can be 
observed in the absence of target. And in the presence of target, a compact structure is formed 
and the fluorophore will be brought close to the quencher, resulting in a fluorescence 
quenching signal. In the work of Stojanovic’s group, 50% quenching was observed with 1 
mmol L
-1
 cocaine.
58
  
In Figure 2-6c, a longer strand and two shorter strands are used. The two shorter strands 
are modified with a fluorophore at the 5’ end, and a quencher at the 3’ end, respectively. 
They are complementary to longer strand at different region, and thus these three strands will 
form a duplex. When the target analyte is in presence, the duplex turns to a target-induced 
complex structure with releasing of quencher-labeled strand and meanwhile give out a 
fluorescence signal.
59
 
And the mechanisms in Figure 2-6d/ 2-6e/ 2-6c are generated based on these strategies 
above. Generally speaking, the fluorescence signaling is ascribed to the conformational 
change of aptamer when binding to the target. And the diversity of aptamer’s structure, 
including secondary or tertiary structure, provides us more possibilities and chances to 
develop the technique in this region. 
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Figure 2-6. Design strategy for aptamer with one fluorophore and one quencher.
54
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2-1-3. RNA aptamer for theophylline detection 
The first reported RNA aptamer for theophylline was exploited by Jenison et al.
23
 As 
shown in Figure 2-7, this 33-mer aptamer provided an internal-loop which acted as a suitable 
pocket for theophylline’s binding event. The binding could be ascribed to molecular shape 
complementarity, stacking interaction and the forming of hydrogen bonding with the receptor 
nucleobase (cytosine). This RNA aptamer showed high binding affinity (dissociation constant 
Kd of 0.3-0.4 M) and specific binding to theophylline (the binding affinity is 10,000-fold 
greater than the RNA molecule’s affinity for caffeine). Therefore, this RNA aptamer could be 
a promising candidate for theophylline detection. 
 
 
Figure 2-7. 33-mer RNA structure and its binding pattern with theophylline.
23
 
 
An application of this RNA aptamer into an electrochemical biosensor was demonstrated 
(Figure 2-8).
23
 The RNA aptamer was immobilized on a gold electrode and the other 
terminal was labeled with a ferrocene (Fc) as a redox probe. In presence of theophylline, the 
aptamer folded into the hairpin structure. This conformational change resulted in increased 
efficiency of eT (decrease in the average eT distance) between the Fc probe and the electrode 
surface. This enabled calibration of the signal versus theophylline concentration. 
 
 
Figure 2-8. Electrochemical biosensor for theophylline based on the RNA aptamer.
24
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However, as we emphasized before, RNA aptamers have some disadvantages. One is 
unstable especially in the biological fluid such as serum and plasma. Another is high cost for 
RNA synthesis compared to DNA. And these disadvantages impede their routine clinical 
application. 
 
 
2-1-4. 2-aminopurine modified DNA aptamer for theophylline detection 
To overcome RNA aptamer’s deficiency, a 2-aminoputine modified DNA aptamer 
(5’-TCTGC GTCCT PXT TAACG CACAC-3’/3’-AGACG CAGGA TCA ATTGC 
GTGTG-5’, P = 2-aminopurine, X = abasic site; Spacer C3, C = receptor nucleobase) has 
been developed by our lab recently.
60
 
An abasic site (AP site) located at the middle of DNA strand was utilized as the active 
binding site. 2-aminopurine (an analogue of adenine) was put into the adjacent place of AP 
site, and worked as a fluorescent probe. The base facing AP site was denoted receptor 
nucleobase, which was expected to form hydrogen bonding with target molecule. (Figure 
2-9A) 
In absence of theophylline, the high fluorescence of 2-aminopurine was observed due to 
the weak stacking interaction with neighboring nucleobase. Upon the binding of theophylline 
molecule, the stacking interaction was improved between 2-aminopurine and neighbors, 
which resulted the fluorescence quenching of 2-aminopurine. And this fluorescence change 
can be used to detect the target molecule—theophylline. 
 
 
Figure 2-9. 2-Aminopurine modified abasic site (AP site)-containing DNA aptamer for theophylline. 
(A) Working scheme; (B) Possible binding mode of cytosine with theophylline.
60
 
 
(B) (A) 
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This aptamer was capable to monitor theophylline’s concentration with a dissociation 
constant of 10 M (at 5C, pH 7.0, I = 0.11 M) by getting a quenching signal when putting 
theophylline into the buffer solution (Figure 2-10). When apply it to detect theophylline in 
serum, a linear response to theophylline concentration was obtained with a good selectivity 
(Figure 2-11). That means we can also apply this DNA aptamer to serum samples.  
 
 
Figure 2-10. Fluorescence response and selectivity to theophylline by using 2-aminopurine modified DNA 
aptamer.
60
 (A) Fluorescence response to theophylline (0-150 M); (B) Binding selectivity for theophylline 
against caffeine, theobromine, uric acid, creatinine, and glucose. 
F and F0 denote the ﬂuorescence intensities in the presence and absence of ligands, respectively. 
[DNA duplex] = 5 M, [NaCl] = 100 mM, [EDTA] = 1.0 mM, [Sodium cacodylate buffer] = 10 mM, pH 
7.0, 5C, Excitation: 320 nm, Analysis: 367 nm. 
 
Figure 2-11. Detection of theophylline in horse serum.
60
 
The control serum samples (5 μl) containing each ligand were diluted to 50 μl with a buffer solution (pH 
7.0, 10 mM sodium cacodylate) containing DNA duplex (5.0 μM), and then the fluorescence 
measurements were done. 
Errors are standard deviations obtained from three independent measurements at each concentration. Other 
conditions are as same as in Figure 2-10. 
(A) (B) 
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However, there are some disadvantages for the practical use. First, it’s a fluorescence 
quenching response to theophylline, which is not preferable for clear fluorescence detection. 
Second, because of the short excitation and emission wavelength of 2-aminopurine 
(Excitation: 320 nm, Emission: 367 nm), a large background fluorescence is present. Third, 
need for the modification of the fluorescent nucleotide analogue makes the assay expensive. 
 
 
2-1-5. Abasic site (AP site) 
An abasic site (AP site), also known as an apurinic/apyrimidinic site, is a location in 
DNA that has neither a purine nor a pyrimidine base, usually due to DNA’s damage. 
AP sites in DNA arise spontaneously by a hydrolytic process that causes a cleavage of 
the N-glycosidic bond and leaves the phosphodiester backbone intact, which is markedly 
accelerated by chemical modification of DNA bases. Approximately 100,000 abasic sites per 
cell are formed each day.
61
 Damaged DNA bases are removed by DNA N-glycosylases, 
generating AP sites as an intermediate during base excision repair. These lesions may play an 
important role in spontaneous and chemical mutagenesis.
62
 The half-life of an AP site in 
oligomeric duplex DNA has been measured by the JoAnne’s group and the Sheppard’s group 
using five different sequence contexts and ranges from 200 to 900 hours under physiological 
conditions (pH 7.5, 150 mM NaCl at 37°C).
63,64
 This means AP site containing DNA duplex 
has a moderate stability even in biological environment. 
The conformation of AP site-containing DNA duplexes’ backbones is generally 
observed as right hand and B-form, but with diversity (Table 2-2). Conformational changes 
due to the presence of the AP site extend to the base pairs adjacent to the lesion site, being 
dependent on the nature of the flanking and opposite bases.
65
 
The structures of DNA oligonucleotides with A, T, G or C opposite an AP site have 
been investigated by Jingyang Chen et al.
 66
 by using 2D NMR. Their results indicate that all 
four kinds of nucleobases opposite the AP site is intrahelical. However, the conformation 
around the AP site is more perturbed when the unpaired base is a pyrimidine (C or T) than a 
purine (A or G). The few available studies tend to indicate that the pyrimidine opposite the 
abasic site may be either stacked inside the helix or expelled outside, or in equilibrium 
between the two situations, depending on the nature of the flanking bases.
65 
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Table 2-2. Diversity of structures of AP site-containing DNAs.
66
 
 
Some AP site analogues were developed
65
 (Figure 2-12) and the two types of AP site 
used in current study are simply listed here (Figure 2-13). dSpacer (a tetrahydrofuranyl 
residue) is commonly used to mimic an abasic site in an oligonucleotide, because it is not 
only structurally very similar to the natural site, but also considerably more stable, and thus 
can tolerate the chemical conditions used in oligo synthesis and purification. The further 
elimination of the five membered ring, only leaving three backbone carbons gives Spacer 
C3 (a propylene residue). 
 
 
Figure 2-12. Structures of AP site and analogues.
65
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Figure 2-13. Structures of dSpacer and Spacer C3. 
 
Besides internal- or stem-loop structures of aptamer, AP site can also be served as a 
suitable pocket for the binding event for target molecules. Conformational changes decrease 
the stability of DNA duplexes with an AP site. In order to form a more chemical stable 
structure, an idea came out that entering a shape suitable molecule to fill up the lesion by 
hydrogen bonding with the opposite base, as well as by stacking interaction and molecular 
shape complementary etc. If it works, this characteristic can be used to specify a certain small 
molecule. Here is a demonstration of an AP site-containing DNA aptamer to identify 
riboflavin developed by our labratory.
67 
This aptamer 23T (23-meric; thymine as receptor nucleobase) is found to show 
selectivity for riboflavin over flavin mononucleotide (FMN) and flavin adenine dinucleotide 
(FAD). (Figure 2-14) 
 
 
 
Figure 2-14. (A) Scheme of AP site-containing aptamer and (B) structures of riboflavin and its 
derivertives.
67
 
 
 
 
 
(B) (A) 
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2-1-6. Serum 
Serum, clear, yellowish fluid, as the component that is neither a blood cell (serum does 
not contain white or red blood cells) nor a clotting factor; it is the blood plasma with 
the fibrinogens removed. Serum includes all proteins not used in blood clotting (coagulation) 
and all the electrolytes, antibodies, antigens, hormones, and any exogenous substances (e.g., 
drugs and microorganisms). Before clotting occurs, the liquid of the blood is called plasma. 
But plasma also contains the protein fibrinogen and certain other elements necessary for 
clotting, and it therefore clots as easily as whole blood. 
Serum is used in numerous diagnostic tests, as well as in blood typing. But because the 
composition of serum is too complex, with hundred kinds of compounds, and the 
batch-to-batch variation effects the consistency of serum products, the exactly gradient and 
concentration of serum is still variety and under research. 
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2-2. Design strategy of our AP-aptamer 
We designed a new modification-free AP site-containing DNA duplex aptamer 
(AP-aptamer) for the detection of theophylline in combination with a fluorescent ligand. As 
schematically shown in Figure 2-15, the present method is based on the competitive binding 
of theophylline and a fluorescent ligand (riboflavin) to the AP site of an AP-aptamer.  
Here, we take riboflavin, also known as vitamin B, as the fluorescent ligand due to its 
binding ability to the AP-aptamer. (It can bind to thymine opposite the AP site in DNA 
duplexes with strong fluorescence quenching.
67,68
) First, fluorescence of riboflavin ligands 
bound to the AP site is strongly quenched when the AP site was flanked by guanine bases.
69
 
And then, when theophylline is in presence, binding of theophylline to the AP site causes the 
release of the fluorescent ligand from the AP site, resulting in the fluorescence restoration. 
And this change of signal can be measured by spectrofluorometer. 
 
 
 
Figure 2-15. Detection scheme for theophylline by using modification-free AP-aptamer.
9
 
 
 
In our previous study, modification of a DNA strand by a fluorescent nucleotide 
analogue, 2-aminopurine, was necessary and fluorescence quenching of 2-aminopurine was 
utilized for the detection of theophylline.
60
 In contrast, emissive response becomes to be 
possible by using modification-free AP-aptamers and AP site-binding ligands according to 
the scheme shown in Figure 2-15. 
In addition, riboflavin shows an emission band in the visible region (absorption 
maximum: 445 nm, emission maximum: 542 nm),
70 
and this fluorescent property is 
preferable for the detection of theophylline in serum samples, since visible light excitation 
can reduce the background fluorescence from serum, compared to ultraviolet excitation.  
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2-3. Optimization of abasic site (AP site)-containing DNA duplex aptamer 
(AP-aptamer) 
2-3-1. Abstract 
We carried out a series experiments to pick out a most likely suitable AP-aptamer for the 
detection of theophylline, based on the competitive binding system with the fluorescent 
molecule-riboflavin. 
The consideration of the optimization mainly concerns the following points: the type of 
receptor nucleobase; the type of AP site; the length of DNA sequence; the selectivity for 
theophylline over other compounds. And after this process, we also decided the properties of 
this chosen AP-aptamer, such as, binding affinity with theophylline; and the detection limit 
for theophylline in buffer and serum samples. 
 
2-3-2. Experimental 
2-3-2-1. Materials and instruments 
Materials 
DNA sequences 
11-meric 
5’-TCCAGXGCAAC-3’ (X = dSpacer, or SpacerC3), (ε260 = 97800 M
-1
cm
-1
) 
3’-AGGTCCCGTTG-5’ (ε260 = 105720 M
-1
cm
-1
) 
3’-AGGTCTCGTTG-5’ (ε260 = 106160 M
-1
cm
-1
) 
3’-AGGTCACGTTG-5’ (ε260 = 110580 M
-1
cm
-1
) 
3’-AGGTCGCGTTG-5’ (ε260 = 108240 M
-1
cm
-1
) 
 
23-meric 
5’-TCTGCGTCCAGXGCAACGCACAC-3’ (X = dSpacer, or SpacerC3), (ε260 = 206380 
M
-1
cm
-1
) 
3’-AGACGCAGGTCCCGTTGCGTGTG-5’ (ε260 = 219980 M
-1
cm
-1
) 
3’-AGACGCAGGTCTCGTTGCGTGTG-5’ (ε260 = 220420 M
-1
cm
-1
) 
 
 
All of the DNA samples were custom synthesized and HPLC purified (>97%) by Nihon 
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Gene Research Laboratories Inc. (Sendai, Japan). The extinction coefficients at 25C were 
calculated at 260 nm for each strand
71
, which was shown in bracket above. 
Riboflavin and theophylline were purchased from Aldrich Chemical Co., (Milwaukee, 
WI) and Wako Pure Chemical Industries, Ltd (Tokyo, Japan), respectively, and they were 
used as received.  
Horse serum was purchased from Kohjin Bio Co., (Saitama, Japan).  
The other reagents were commercially available analytical grade and were used without 
further purification. Water was deionized (18.0 M cm specific resistance) by an Elix 5 UV 
Water Purification System and a Milli-Q Synthesis A10 system (Millipore Corp., Bedford, 
MA). 
 
 
Instruments 
Fluorescence measurement: Fluorescence spectra were measured with a JASCO model 
FP-6500 spectrofluorophotometer equipped with a thermoelectrically temperature-controlled 
cell holder (Japan Spectroscopic Co. Ltd., Tokyo, Japan). It was previously found that the 
binding affinity of pterin with guanine opposite an AP site increased more than 10 times at 
5C compared to 20C.72 Accordingly, fluorescence measurements were carried out at 5C 
using a 3  3 mm quartz cell. Excitation wavelength for riboflavin was set at 448 nm, which 
was the maximum absorption wavelength of riboflavin. 
UV measurement: JASCO model V-570 spectrophotometer. 
 
 
Preparation of stock solutions 
DNA solutions: The concentrations of DNAs were determined from the molar extinction 
coefficients at 260 nm. Stock solutions were prepared with miliQ water to 250 M and stored 
at 4C. 
Buffer solution: Stock solution was prepared in 100 ml miliQ water and containing 
sodium cacodylate (1.071g, 50 mM), NaCl (2.935g, 500 mM), EDTA (0.187g, 5.0 mM), and 
stored at 4C. When applied it into tubes, it was 5 times diluted, which made the standard 
buffer solution’s concentration as follows: [sodium cacodylate] = 10 mM, [NaCl] = 100 mM, 
[EDTA] = 1.0 mM. 
Sodium cacodylate buffer solution: Stock solution was prepared in 25 ml miliQ water 
and containing sodium cacodylate (263.47 mg, 50 mM), and stored at 4C. 
(-)-Riboflavin solution: Stock solution was prepared in 50 ml miliQ water and 
containing riboflavin (1.38 mg, 73.33 M), and stored at 4C. 
Theophylline solution: Stock solution was prepared in 100 ml miliQ water and 
containing theophylline (54.9 mg, 3.05 mM), and stored at 4C. 
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Caffeine solution: Stock solution was prepared in 50 ml miliQ water and containing 
caffeine (9.92 mg, 1.02 mM), and stored at 4C. 
Theobromine solution: Stock solution was prepared in 50 ml miliQ water and containing 
theobromine (9.50 mg, 1.05 mM), and stored at 4C. 
Uric acid solution: Stock solution was prepared in 50 ml miliQ water and containing uric 
acid (8.78 mg, 1.04 mM), and stored at 4C. 
Creatinine solution: Stock solution was prepared in 50 ml miliQ water and containing 
creatinine (5.77 mg, 1.02 mM), and stored at 4C. 
D(+)-glucose solution: Stock solution was prepared in 50 ml miliQ water and containing 
glucose (9.83 mg, 1.09 mM), and stored at 4C. 
 
Experiment conditions 
In Chapter 2, unless otherwise mentioned, all measurements were performed in 
standard buffer solution: 10 mM sodium cacodylate buffer solutions (pH 7.0) containing 
100 mM NaCl and 1.0 mM EDTA. Before measurements, the sample solutions were 
annealed as follows: heated at 75C for 10 min, and gradually cooled to 5C (3C/min), after 
which the solution temperature was raised again to 20C. 
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2-3-2-2. Determination of binding constants of DNA-theophylline interactions 
based on the competitive binding model.  
The competitive binding system is considered as the combination of two 1:1 binding 
events including DNA-riboflavin interactions and DNA-theophylline interactions. Then, the 
following equilibria are considered to describe the present system.  
  DNA + Ligand
Kl
DNA-Ligand      (1) 
DNA + Theophylline
Kt
DNA-Theophylline    (2) 
Kl = [DNA-Ligand]/[DNA][Ligand]                  (3) 
Kt = [DNA-Theophylline]/[DNA][Theophylline]         (4) 
Total concentrations of DNA (Cd), Ligand (Cl), Theophylline (Ct) can be expressed by 
the following equations: 
Cd = [DNA] + [DNA-Ligand] + [DNA-Target]           (5) 
Cl = [Ligand] + [DNA-Ligand]                      (6) 
Ct = [Target] + [DNA-Target]                       (7) 
By combining the equations (3)-(7), Ct can be expressed as follows:  
Ct = (Cl - [Ligand] – CdKl [Ligand] + ClKl [Ligand] - Kl [Ligand]
2
)/ KlKt [Ligand] ([Ligand] - Cl)   (8) 
On the other hand, the fluorescence intensity can be interpreted as the sum of each 
contribution as follows: 
F = kd [DNA] + kl [Ligand] + kt [Target] + kdl [DNA-Ligand] + kdt [DNA-Target]         (9) 
where the k represents proportionality constants connecting the fluorescence intensities and 
concentrations of the species (kd: free DNA, kl: free ligand, kt: free target, kdl: 1:1 DNA-ligand 
complex, kdt: 1:1 DNA-target complex). In this equation, free DNA, free target, and 
DNA-target complex are not fluorescent components. In addition, the DNA-ligand complex 
is also assumed as no contributor based on the fact that this complex shows almost no 
fluorescence when all riboflavin molecule forms the complex with DNA molecules at the 
high excess DNA concentration
59,60
 and then, equation (9) can be rewritten by the following 
simple form: 
F = kl [Ligand]     (10) 
Using the relationship of the fluorescence intensity of a ligand in the absence of DNA 
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and target (F0 = kl Cl), the following equation can be derived.  
F/F0 = [Ligand]/Cl     (11) 
Together, equations (8) and (11) describe the present system. And the plot of Ct versus 
F/F0 was fitted by the equation combined equations (8) and (11), which gives the value of Kt.  
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2-3-3. Results and discussions 
2-3-3-1. Properties of riboflavin 
2-3-3-1-1. Basic properties of riboflavin 
To determine the fluorescence characteristics of riboflavin, we examined UV and 
fluorescence excitation / emission spectra under our standard buffer conditions. 
We calculated the molar extinction coefficient (11753 M
-1
cm
-1
) from Figure 2-16, and 
determined the maximum absorption wavelength as 448 nm. 
 
 
0.0
0.050
0.10
0.15
0.20
0.25
0.30
0 5 10 15 20 25
y = 0.0020757 + 0.011753x   R= 0.99987 
A
b
s
.
[Riboflavin] / M  
Figure 2-16. UV spectra of riboflavin. 
[riboflavin] = 0, 5, 10, 15, 20, 25 M, buffer, pH 7.0, 20C, 1010 mm quartz cell (optical path length: 10 
mm), Analysis: 448 nm. 
 
 
 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
200 250 300 350 400 450 500 550
A
b
s
.
wavelength / nm
25 M
20 M
15 M
10 M
5.0 M
0.0 M
0.0
0.1
0.2
0.3
0.4
300 350 400 450 500
A
b
s
.
wavelength / nm
25 M
20 M
15 M
10 M
5.0 M
0.0 M
HN
N N
N
O
O
CH3
CH3
OH
HO
OH
OH
Riboflavin 
448 = 11753 M
-1
cm
-1
 
31 
 
  
Figure 2-17. Emission spectra of riboflavin. 
[riboflavin] = 0, 3, 6, 9, 12, 15 M, buffer, pH 7.0, 20C, 33 mm quartz cell, Excitation: 448 nm, Analysis: 
530 nm. 
 
 
   
Figure 2-18. Excitation spectra of riboflavin. 
[riboflavin] = 0, 3, 6, 9, 12, 15 M, buffer, pH 7.0, 20C, 33 mm quartz cell, Excitation: 448 nm, Analysis: 
448 nm. 
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2-3-3-1-2. Comparison of the excitation wavelength 
We got an isosbestic point (478nm) by UV spectra (Figure 2-19) when adding 11-mer 
AP-aptamer and theophylline into the riboflavin solution. In order to compare the effect of 
excitation wavelength, we took fluorescence measurements under the maximum absorption 
wavelength (448nm, Figure 2-20) and the isosbestic point wavelength (478nm, Figure 2-21), 
and the results were listed in Table 2-3. 
 
  
Figure 2-19. UV spectra for AP-aptamer and riboflavin interactions: (A) dSpacer, (B) SpacerC3. 
[11-mer AP-aptamer] = 5.0 M, [riboflavin] = 5.0 M, buffer, pH 7.0, 20C, 110 mm quartz cell (optical 
path length: 10 mm). 
 
 
  
Figure 2-20. Fluorescent spectra excited at 448 nm: (A) dSpacer, (B) SpacerC3. 
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, buffer, pH 7.0, 20C, 33 mm quartz cell, Analysis: 
530 nm. 
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Figure 2-21. Fluorescent spectra excited at 478 nm: (A) dSpacer, (B) SpacerC3. 
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, buffer, pH 7.0, 20C, 33 mm quartz cell, Analysis: 
530 nm. 
 
F/F0   Ex.448nm Ex.478nm 
dSpacer G 0.91 0.91 
 C 0.67 0.70 
 A 0.92 0.91 
 T 0.63 0.65 
SpacerC3 G 0.90 0.89 
 C 0.63 0.65 
 A 0.90 0.89 
  T 0.54 0.56 
Table 2-3. Comparison of the fluorescent ratio excited at maximum absorption wavelength (448nm) and 
the isosbestic point wavelength (478nm), respectively. 
F0: DNA free in solution (only riboflavin; without AP-aptamers). 
 
From the listed data of Table 2-3, we can get the conclusion that there is rarely difference by 
using these two excitation wavelengths, respectively. We chose the maximum absorption 
wavelength (448 nm) as the excitation wavelength by tradition. 
 
 
2-3-3-1-3. Effect of temperature 
We took out experiments under room temperature (20C) and decreased temperature 
(5C), and the results turned out the measurements at lower temperature gave out more 
efficient quenching signals, especially for C and T (Figure 2-22). In order to get a clearly 
quenching, we chose 5C as the measurement temperature for further experiments. However, 
it should be pointed out that our system is applicable at various temperatures including room 
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temperature, but not only at 5C. 
It probably can be explained in this way: At a low temperature, the DNA duplexes are 
more stable and thus the DNA-riboflavin complexes should be more stable. In contrast, as the 
temperature rises up, more and more DNA duplexes would have a trend to separate to single 
strands. As a result, the adoption pockets for riboflavin decreases, which leads to the 
quenching less efficiency. 
 
  
  
Figure 2-22. Fluorescence spectra at 20C (A, B) and 5C (C, D).  
(A), (C): dSpacer; (B), (D): SpacerC3. 
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, buffer, pH 7.0, 20C or 5C, 33 mm quartz cell, 
Excitation: 448 nm. 
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2-3-3-2. Optimization of aptamer: the receptor nucleobase  
For the optimization of aptamer, first, we examined the fluorescence response of 
riboflavin (10 M) upon addition of 11-mer AP-aptamers (10 M; 5’-TCCAGXGCAAC-3’/ 
3’-AGGTCNCGTTG-5’, X = Spacer C3, N = G, C, A or T) having guanine (11G), cytosine 
(11C), adenine (11A), or thymine (11T) as a receptor nucleobase in a standard buffer solution 
of pH 7.0. 
As shown in Figure 2-23 (A)-(D), riboflavin shows fluorescence quenching ability for 
AP-aptamers with all four kinds of receptor nucleobases. However, the quenching degree 
various, suggesting the binding of riboflavin at AP site depends on the type of receptor 
nucleobase.  
The fluorescence quenching of riboflavin is most significant for 11T (Figure 2-23(D)), 
followed with 11C (Figure 2-23(B)), while the response is small for 11G (Figure 2-23(A)) 
and 11A (Figure 2-23(C)). 
The fluorescence restoration was examined by adding 100 M theophylline. Again, 11C 
and 11T exhibit significant fluorescence restoration upon addition of theophylline, while 
there are only moderate responses for 11G and 11A. This strong response of 11C and 11T can 
be ascribed to the exchange and release of riboflavin from the competitive binding with 
theophylline. 
These results show that the combination of riboflavin with 11C or 11T is likely to be 
suitable for further experiments. 
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Figure 2-23. Fluorescence spectra of riboflavin in the absence (black dot line) and presence (black solid 
line) of 11-mer AP-aptamers: (A) 11G, (B) 11C, (C) 11A, and (D) 11T.  
Fluorescence responses of riboflavin with AP-aptamers to theophylline are also shown (red solid line). 
 
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, [theophylline] = 100 M, buffer, pH 7.0, 5C, 
Excitation: 448 nm. 
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We also measured the melting temperatures of 11-mer AP-aptamers (10 M) with and 
without theophylline (50 M). The data was summarized in Table 2-4. Although all 
sequences reached a higher melting temperature after adding theophylline, which means the 
complexes are more stable than DNA duplexes alone, 11C and 11T show a higher Tm 
comparing to 11G and 11A. Therefore, 11C and 11T are likely more suitable for further 
investigation. This result is in accordance with our previous conclusion, which derived from 
the fluorescence spectra. 
 
 
 
    Tm (-) Tm (+) Tm
dSpacer G 30.8 ± 0.1 31.6 ± 1.1 0.8 
 C 26.2 ± 0.5 28.2 ± 0.2 2.0 
 A 31.5 ± 0.8 32.3 ± 0.2 0.8 
  T 25.5 ± 0.1 28.5 ± 0.5 3.0 
SpacerC3 G 31.0 ± 0.7 32.7 ± 0.1 1.7 
 C 26.0 ± 0.4 28.8 ± 0.2 2.8 
 A 30.3 ± 0.6 31.2 ± 0.6 0.9 
  T 23.7 ± 0.5 28.4 ± 0.2 4.7 
 
Table 2-4. Melting temperature of 11-mer AP-aptamers and theophylline complex (n = 3). 
[11-mer AP-aptamer] = 10 M, [theophylline] = 50 M, buffer, pH 7.0, 8 cells micro-multicell holder 
(optical path length: 1 mm), Shimadzu UV-2450 UV/Visible Spectrophotometer. 
Tm (-) represents the melting temperature of only 11-mer AP-aptamer, and Tm (+) represents the melting 
temperature of 11-mer AP-aptamers and theophylline complex. Therefore, Tm shows the changed value, 
Tm = Tm (+)-Tm (-).  
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2-3-3-3. Effect of the type of AP site on the AP-aptamer 
When we used dSpacer as the AP site of 11-mer AP-aptamers instead of Spacer C3, the 
fluorescence response upon addition of theophylline (Figure 2-24) was similar to those 
shown in Figure 2-23. But the response is slightly smaller for dSpacer than that for Spacer 
C3 (Table 2-5). Therefore, Spacer C3 was considered to be better in the further experiments. 
 
 
Figure 2-24. Fluorescence spectra by using dSpacer as an AP site. 
 (A) 11G, (B) 11C, (C) 11A, and (D) 11T.  
All other conditions are as same as given in Figure 2-23. 
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, [theophylline] = 100 M, buffer, pH 7.0, 5C, 
Excitation: 448 nm. 
 
 
From Table 2-5, it is clear that all four kinds of receptor nucleobases show larger 
recovery ability when oppositing place is a SpacerC3 type AP site. In addition, C and T show 
13% and 15% enlarging by using SpacerC3 than dSpacer, respectively, which cannot be 
ignored. 
 
(B) (A) 
(D) (C) 
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  SpacerC3 dSpacer Recovery ratio % 
  F. I. Q % F. I. R % F. I. Q % F. I. R % SpacerC3 dSpacer 
G 97.84  83.7 102.70  87.8 104.50  89.4 104.92  89.7 4.1 0.3 
C 50.26  43.0 103.52  88.5 55.98  47.9 93.84  80.2 45.5 32.3 
A 95.60  81.7 103.97  88.9 106.05  90.7 106.25  90.9 7.2 0.2 
T 35.12  30.0 75.34  64.4 45.14  38.6 67.45  57.7 34.4 19.1 
Table 2-5. Comparison of quenching and restoration efficiency by using SpacerC3 and dSpacer. 
F.I. represents fluorescence intensity; Q represents quenching efficiency; R represents recovery efficiency, 
respectively. The percentages come from the fluorescence intensity of each value versus the value when 
only riboflavin existed in buffer solution. Analysis: 530 nm. 
 
 
2-3-3-4. Selectivity for theophylline (Comparison with related molecules) 
Next, we examined the fluorescence response to the structurally-related methylxanthine 
derivatives including caffeine and theobromine, and the molecules present in serum (Figure 
2-25).  
Significantly, riboflavin/11C shows little response to either caffeine or theobromine and 
the responses to other molecules such as uric acid, creatinine, and D-glucose that are present 
in serum are only negligible (Figure 2-26(A)).  
On the other hand, riboflavin/11T exhibits the effective fluorescence response to not 
only theophylline but also caffeine and theobromine whereas almost no or moderate response 
are observed for other substrates (Figure 2-26(B)).  
By now, we successfully obtain a clear and selective response of riboflavin/11C for the 
fluorescence detection of theophylline. Such highly selectivity for theophylline can be 
ascribed to the possible formation of the hydrogen bonding between theophylline and the 
receptor cytosine nucleotide at the AP site of 11C,
60
 similarly to the recognition of 
theophylline by RNA aptamers.
23,43,44
 Whereas for caffeine or theobromine, the single methyl 
group attached to the xanthine ring restricts the forming of hydrogen bondings. 
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Figure 2-25. Structures of theophylline, caffeine, theobromine and other compounds existed in serum. 
 
 
 
 
Figure 2-26. Fluorescence responses of (A) riboflavin/11C and (B) riboflavin/11T to target molecules:  
(a) theophylline, (b) caffeine, (c) theobromine, (d) uric acid, (e) creatinine, and (f) glucose.  
[11-mer AP-aptamer] = 10 M, [riboflavin] = 10 M, [Target] = 100 M, buffer, pH 7.0, 5C, Excitation: 
448 nm. 
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2-3-3-5. Determination of the binding affinity between 11C and theophylline 
The binding affinity of 11C to theophylline was quantitatively assessed by the 
fluorescence titration experiments, for which changes in the fluorescence intensity of 
riboflavin/11C were measured with increasing the concentration of theophylline. As shown in 
Figure 2-27, the fluorescence response of riboflavin/11C to theophylline is 
concentration-dependent. The resulting titration curve is well analyzed by the competitive 
binding model including 11C-riboflavin and 11C-theophylline interactions (Figure 2-28). For 
this analysis, we used the 1:1 binding affinity of 11C to riboflavin (Kl) of (3.6  0.1)  10
5
 
M
-1
 (n = 3) that was independently determined from fluorescence titration experiments 
(Figure 2-29). By using this value of Kl, the 1:1 binding affinity of 11C to theophylline (Kt) 
was then determined as (1.1  0.1)  105 M-1 (n = 3). This gives the dissociation constant (Kd 
= 1/Kt) of 9.1 M, which is comparable to that of our previous 2-aminopurine modified DNA 
duplex aptamer (Kd = 10 M).
60
  
 
 
Figure 2-27. Fluorescence responses of riboflavin/11C to theophylline.
9
 
Inset: Fluorescence intensity change at 530 nm of riboflavin/11C upon addition of theophylline.  F and F0 
denote the fluorescence intensities of riboflavin/11C in the presence and absence of theophylline, 
respectively. 
[11C] = 10 M, [riboflavin] = 10 M, [theophylline] = 0-300 M, buffer, pH 7.0, 5C, Excitation: 448 nm, 
Analysis: 530 nm. 
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Figure 2-28. Non-linear regression analysis of the changes in the fluorescence intensity ratio at 530 nm of 
riboflavin/11C upon addition of theophylline.
9
 
Other solution conditions are the same as those given in Figure 2-27. 
F and F0 denote the fluorescence intensities of riboflavin in the presence and absence of both DNAs and 
theophylline, respectively. 
 
 
Figure 2-29. Fluorescence response of riboflavin (10 M) to 11C.
9
 
Inset: Non-linear regression analysis of the changes in the fluorescence intensity ratio at 530 nm based on a 
1:1 binding isotherm model.
73
 
F and F0 denote the fluorescence intensities of riboflavin in the presence and absence of DNA duplexes, 
respectively. 
[11C] = 0, 5, 7.5, 10, 12.5, 15, 30, 50 M, [riboflavin] = 10 M, buffer, pH 7.0, 5C, Excitation: 448 nm, 
Analysis: 530 nm. 
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2-3-3-6. Optimization of DNA’s length 
Since the binding affinity of AP site-binding ligands to the receptor nucleotide opposite 
the AP site depends on the length of DNA duplexes,
3 
we examined the fluorescence response 
to theophylline by utilizing 23-mer (23C; 5’-T CTG CGT CCA GXG CAA CGC ACA C-3’/ 
3’-A GAC GCA GGT CCC GTT GCG TGT G-5’, X = SpacerC3), 35-mer (35C; 5’-A TAA 
CGT CTG CGT CCA GXG CAA CGC ACA CAC GCA T-3’/ 3’-T ATT GCA GAC GCA 
GGT CCC GTT GCG TGT GTG CGT A-5’, X = SpacerC3), and 47-mer (47C; 5’-CAGC 
CGA TAA CGT CTG CGT CCA GXG CAA CGC ACA CAC GCA TAT GTGC-3’/ 3’-GTCG 
GCT ATT GCA GAC GCA GGT CCC GTT GCG TGT GTG CGT ATA CACG-5’ , X = 
SpacerC3) AP-aptamer having cytosine as the receptor nucleobase. 
23C, 35C and 47C/riboflavin complexes show stronger fluoresence quenching and 
restoration ability than 11C/riboflavin, sugguesing longer DNAs are preferred. However, 
compared with 23C, longer DNAs (35C and 47C) didn’t show better performance upon 
addition of theophylline (Figure 2-30). Therefore, we consider 23-mer is a proper length of 
AP-aptamer for further experiments. 
 
 
 
Figure 2-30. (A) Fluorescence quenching spectra of the complex of riboflavin with 11C, 23C, 35C, or 47C; 
(B) Fluorescence restoration upon addition of theophylline. 
[DNA duplex] = 10 M, [riboflavin] = 10 M, [theophylline] = (A) 10 M; or (B) 0, 10, 25, 50, 100, 150, 
200, 250, 300 M, buffer, pH 7.0, 5C, 33 mm quartz cell, Ex band: 3 nm, Em band: 3 nm, Excitation: 
448 nm, Analysis:530 nm. F0 : without target. 
 
 
 
(B) (A) 
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2-3-3-7. Determination of the binding affinity between 23C and theophylline 
We examined the affinities of 23-mer AP-aptamers (23C) to riboflavin (Figure 2-31) 
and theophylline (Figure 2-32) by the fluorescence titration experiments. As compared to the 
affinity of 11C to riboflavin, the affinity of 23C slightly increases (Kl = (4.3  0.2)  10
5
 M
-1
, 
n = 3). And the affinity of riboflavin/23C to theophylline (Kt = (1.2  0.1)  10
5
 M
-1
, n = 3) is 
comparable with that of 11C (Table 2-6). Although the observed the binding affinity varies 
not so much, the stronger binding affinity of riboflavin-23C leads to the more efficient 
quenching signaling for a clear detection of theophylline in our assay. 
 
 
Figure 2-31. Fluorescence response of riboflavin (10 M) to 23C. 
Inset: Non-linear regression analysis of the changes in the fluorescence intensity ratio at 530 nm based on a 
1:1 binding isotherm model.
73
 
F and F0 denote the fluorescence intensities of riboflavin in the presence and absence of DNA duplexes, 
respectively.  
[23C] = 0, 5, 7.5, 10, 12.5, 15, 30, 50 M, [riboflavin] = 10 M, buffer, pH 7.0, 5C, Excitation: 448 nm, 
Analysis: 530 nm. 
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Figure 2-32. Fluorescence responses of riboflavin (10.0 M)/23C (10.0 M) to theophylline (0-300 M). 
Inset: Non-linear regression analysis of the changes in the fluorescence intensity ratio at 530 nm based on 
the competitive binding model.  
F and F0 denote the fluorescence intensities of riboflavin in the presence and absence of both DNAs and 
theophylline, respectively. 
[23C] = 10 M, [riboflavin] = 10 M, [theophylline] = 0, 10, 25, 50, 100, 150, 200, 250, 300 M, buffer, 
pH=7.0, 5C, Excitation: 448 nm, Analysis: 530 nm. 
 
 
 
K11 (n  3) 11C 23C 
AP-aptamer/riboflavin (10
5
M
-1
) 3.6  0.1 4.3  0.2 
AP-aptamer/theophylline (10
5
M
-1
) 1.1  0.1 1.2  0.1 
Table 2-6. Binding constants for 11C and 23C 
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2-3-3-8. Binding selectivity and limit of detection of 23C 
Importantly, riboflavin/23C shows high selective response to theophylline in the 
concentration range of 10 to 250 M (Figure 2-33) over caffeine and theobromine, similarly 
to riboflavin/11C. This result indicates that highly selectivity to theophylline is maintained 
irrespective of the DNA length. Therefore, it can be concluded that 23C qualifies as a 
promising DNA duplex for further experiments.  
 
 
Figure 2-33. Fluorescence responses of riboflavin (5.0 M)/23C (5.0 M) to target molecules (0-250 M): 
(a) theophylline, (b) caffeine, (c) theobromine, (d) uric acid, (e) creatinine, and (f) glucose. 
F and F0 denote the fluorescence intensities of riboflavin/11C in the presence and absence of target, 
respectively.  
[23C] = 5 M, [riboflavin] = 5 M, [Target] =0, 10, 25, 50, 150, 250 M, buffer, pH 7.0, 5C, Excitation: 
448 nm, Analysis: 530 nm. 
 
The examination of the limit of detection (LOD) for theophylline reveals the promising 
ability of riboflavin/23C. The response of riboflavin/23C was found to increase linearly as 
the concentration of theophylline increased from 2.5 M to 10 M (Figure 2-34). The 
resulting linear equation was y = 1.0 + 0.035x (R = 0.9982). The LOD can be estimated by the 
following eq (1): 
(1) 
where Sblank and m are the standard deviation of the blank and the slope obatined from the 
linear fitting, respectively. From three independent experiments, the value of Sblank was 
determined as 0.013. Thus, LOD was estimated as 1.1 M and this value is almost 
comparable to that of theophylline-binding RNA aptamer-based methods (0.1-1.2 M).24-29 
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Figure 2-34. The linear fitting analysis for the determination of detection of limit (LOD) for theophylline 
based on the response of riboflavin (10.0 M)/23C (10.0 M). 
F and F0 denote the fluorescence intensities of riboflavin/23C in the presence and absence of theophylline, 
respectively. Error bars represent the standard deviations obtained from three independent experiments. 
[23C] = 10 M, [riboflavin] = 10 M, [theophylline] = 0, 0.25, 0.5, 1.5, 2.5, 6, 10 M, buffer, pH 7.0, 5C, 
33 mm quartz cell, Ex band: 3 nm, Em band: 3 nm, Excitation: 448 nm, Analysis: 530 nm. 
 
2-3-3-9. Binding mode 
As mentioned earlier, the efficient fluorescence signal of AP-aptamer for theophylline 
may ascribe to the formation of two hydrogen bondings between theophylline and the 
receptor nucleobase cytosine. The N-7 hydrogen and C-6 keto oxygen of theophylline are 
critical.
23,60
 The bonding pattern can be illustrated as the following figure: 
 
 
Figure 2-35. Binding mode between theophylline and cytosine. 
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2-4. Application of the aptamer into biological sample (horse serum) 
Finally, we applied our 23-mer AP-aptamer into real serum samples. 
2-4-1. Experimental 
The preparation procedure of samples is simple and rapid, without pre-purification of 
serum. This is a significant progress comparing with immunoassays and routine gas/liquid 
chromatographic methods. A horse serum sample containing theophylline (10 l) was diluted 
to 50 l with a buffer solution (40 l, pH 7.0) containing 23C (10 M) and riboflavin (10 
M). Then, the fluorescence spectra of the resulting solutions (50 l) can be measured. And 
the response for caffeine and theobromine were also measured. 
 
 
Figure 2-36. Sample preparation for fluorescence measurement. 
 
2-4-2. Results and discussion 
As shown in Figure 2-37, the background fluorescence from serum is negligible under 
the present conditions, which provides the clear monitoring of the fluorescence signaling of 
riboflavin/23C even in the serum samples. We also compared the inherent background of 
serum under the same condition with previous 2-aminopurine aptamer
60
. The background 
nature of serum itself is decreased to nearly one sixth at the analysis wavelength related to 
each research. The result shows that using riboflavin/23C under present condition can 
significantly avoid the background (Figure 2-38, Table 2-7). This is one important advantage 
of our AP-aptamer. 
On the other hand, the riboflavin/23C complex was found to show the effective response 
to theophylline whereas almost no response appeared for caffeine and theobromine (Figure 
2-37), indicating that riboflavin/23C can be used for highly selective detection for 
theophylline in serum samples. In addition, a good linear correlation was obtained between 
the fluorescence response and the concentration of theophylline ranged from 10 M to 32.5 
49 
 
M (Figure 2-39), which corresponds to the concentration range from 50 M to 162.5 M in 
the original serum samples. Therefore, riboflavin/23C is applicable to the monitoring of 
serum theophylline in the therapeutic range (60-100 M).12 
 
Figure 2-37. Fluorescence response for theophylline, theobromine and caffeine (10-32.5 M) in horse 
serum samples. 
[23C] = 10 M, [riboflavin] = 10 M, [theophylline (or theobromine or caffeine) in serum solution] = 10, 
17.5, 25, 32.5 M, horse serum 10 l, [sodium cacodylate] = 10 mM, pH 7.0, 5C, Sample volume: 50 l, 
Excitation: 448 nm. 
 
 
Figure 2-38. Comparison of serum background at different excitation wavelengths. 
horse serum 10 l, [sodium cacodylate] = 10 mM, pH 7.0, 5C. 
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 Ex. / nm Analy./ nm Fl. Int. / a. u. 
2-aminopurine aptamer 320 367 12.396 
present AP-aptamer 448 530 2.243 
Table 2-7. Comparison of serum background at wavelength related to each research. 
 
 
 
Figure 2-39. The linear response for theophylline and the selectivity over caffeine and theobromine by 
using riboflavin/23C. 
F and F0’ denote the fluorescence intensities of riboflavin/23C in the presence and absence of theophylline, 
respectively. Experiment conditions are as same as given in Figure 2-37, analysis at 530 nm. 
 
Under the present experimental conditions, LOD for theophylline was determined as 8.0 
M in the original serum samples according to eq (1) in the section 2-3-3-8. As for the 
response to theophylline, the equation obtained by the linear fitting (Figure 2-39) is y = 1.01 
+ 0.00875 x (R = 0.9956). The standard deviation of blank (Sblank) is 0.00456. According to 
the equation (1), LOD was thus estimated as 1.6 M, which corresponds to 8.0 M in the 
original serum samples. 
 
 
In order to estimate the response time for riboflavin/23C complex after adding 
theophylline, we carried out another experiment for fluorescence response ratio versus the 
time by using a same sample (Figure 2-30). The result shows the response was soon observed 
after adding theophylline and it kept for a certain time without significant change although a 
gradual decrease existed. The gradual decrease in fluorescence intensity may because of 
photobleaching of riboflavin. In conclusion, the detection can be carried out within a short 
period and the consistency would keep at least in 90 min. 
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Figure 2-30. Fluorescence response ratio versus the time (0, 1, 2, 3, 5, 7, 10, 15, 20, 25, 30, 35, 40, 45, 50, 
55, 60, 70, 90 min). 
F and F0 denote the fluorescence intensities of riboflavin in the presence and absence of both DNAs and 
theophylline, respectively. 
[23C] = 10 M, [riboflavin] = 10 M, [theophylline in serum solution] = 25 M, horse serum 10 l, 
[sodium cacodylate] = 10 mM, pH 7.0, 5C, Excitation: 448 nm, Analysis: 530 nm. 
 
 
When the interfering molecules (theobromine and caffeine) are coexisted in serum, the 
response to theophylline is not influenced (Figure 2-31). This result strongly supported the 
applicability for riboflavin/23C to biological samples. 
 
 
Figure 2-31. Effect of interfering molecules to the response 
(A) Fluorescence spectra for theophylline alone and theophylline with theobromine or caffeine;  
(B) Bar figure for (a) theophylline alone, (b) theophylline with theobromine, (c) theophylline with caffeine, 
and (d) theophylline with both theobromine and caffeine. 
[23C] = 10 M, [riboflavin] = 10 M, [theophylline or theobromine or caffeine in serum solution] = 25 
M, horse serum 10 l, [sodium cacodylate] = 10 mM, pH 7.0, 5C, Excitation: 448 nm, Analysis: 530 nm 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 20 40 60 80
F
 /
 F
0
Time / min
0
20
40
60
80
100
120
500 550 600 650 700
F
l.
 I
n
t.
 /
 a
. 
u
.
wavelength / nm
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
F
/ 
F
0
(a)      (b)     (c)     (d) 
(A) (B) 
52 
 
As is demonstrated here, theophylline in serum samples is ready to be analyzed in serum 
based on the fluorescence response of riboflavin/23C without any cumbersome pretreatment 
such as deproteinization and solvent extraction, which is significantly advantageous with a 
view toward development of new aptamer-based methods suitable for practical use by 
choosing a suitable combination of AP-aptamers and ligands for specific targets.  
 
 
2-5. Conclusion 
In conclusion, we developed a new competitive assay for fluorescent detection of 
theophylline based on a modification-free AP site-containing DNA duplex aptamer 
(AP-aptamer) in combination with an AP site-binding ligand, riboflavin. By the competitive 
binding of theophylline and riboflavin at the AP site in the AP-aptamer, quenched 
fluorescence of riboflavin bound to the AP site was restored due to the release of riboflavin 
from the AP site to the solution phase.  
Fluorescence response showed a good linear correlation to the concentration of 
theophylline ranged from 10 M to 32.5 M in horse serum samples, and little response was 
observed for caffeine and theobromine. Importantly, this range corresponds to the 
concentration range from 50 M to 162.5 M in the original serum samples, which covers the 
therapeutic range (60-100 M).  
Due to the high selectivity for theophylline, the present method could be successfully 
applicable to detect serum theophylline in a therapeutic concentration range. Since neither the 
covalent labeling with signal transduction units nor the modification with the fluorescent 
nucleotide analogues is required, the proposed assay is simpler, easier, and more 
cost-effective than typical assays based on theophylline-binding RNA-aptamers. These 
characteristics of the proposed method are clearly advantageous for practical use.  
Compared with 2-aminopurine modified DNA aptamer, our AP-aptamer gives a missive 
response to theophylline with low background fluorescence from serum, and the modification 
free character makes the assay much cheaper. 
We expect that such characteristics allow the design of the label- and modification-free 
AP-aptamer-based assays targeting various kinds of small molecules. We are now 
undertaking further studies in this direction. 
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Chapter 3: Development of a highly selective ligand binding with cytosine 
opposite an abasic site in DNA duplexes
74 
 
3-1. Introduction 
3-1-1. SNPs 
Single Nucleotide Polymorphisms (SNPs, pronounced ‘snips’) are the most common 
happened DNA sequence mutation, occurring with a single nucleotide (A, T, C or G) in the 
genome. For example, a SNP may replace the nucleotide adenosine (A) with the nucleotide 
guanine (G) in a certain location of DNA. 
All humans have almost the same sequence of 3 billion DNA nucleotides distributed 
between their 23 pairs of chromosomes. But there may be up to 0.1% of our DNA various at 
certain locations, what makes individuals different from one another. This means in our 
genome, there are about 3 million SNPs existing, which is a huge amount of variation 
deserving to be studied. On the other hand, we can also use the mutation of SNP as biological 
markers, helping scientists locate genes that are associated with disease.
75,76
 
SNPs become important to study because of their ability to influence disease risk, drug 
efficacy and side-effects. For example, a single base mutation in the APOE (apolipoprotein E) 
gene is associated with a higher risk for Alzheimer disease.
77
 Furthermore, SNPs are probably 
the most important category of genetic changes influencing common diseases. In terms of 
common diseases, 9 of the top 10 leading causes of death have a genetic component and thus 
most likely one or more SNPs influence your disease risk.
78
 
In conclusion, SNPs in human genome is crucial important to study for the fields of 
genetics, diagnostics and disease research. 
 
 
3-1-2. Existent small ligands for SNPs detection by using AP site-containing 
DNA duplex 
A series of small ligands have been found with highly selective binding ability to a 
nucleobase opposite an abasic site (AP site) in DNA duplexes. These ligands have been 
designed intentionally with a fluorescent emit signal upon the binding with DNA duplexes. 
This strategy of small ligand-based fluorescence assay for SNPs detection has been proposed 
as shown in Figure 3-1.  
57 
 
 
Figure 3-1.  Schematic illustration of the ligand binding to nucleobases opposite an AP site in a DNA 
duplex. 
 
As different with canonical DNA-small ligand binding, such as intercalation
79
 or groove 
binding
80
, it is characteristic of ligands to bind to non-Watson–Crick base-pairing sites in 
DNA duplexes, where the binding is selectively promoted by a pseudo-base pairing along the 
Watson–Crick edge of the intrahelical target nucleobases.81 A classic example is the 
mismatch-binding ligands developed by Nakatani and co-workers, and a surface plasmon 
resonance (SPR) assay has been proposed based on forming of these pseudo-base pairs.
82-84
 
In our approach, we chose AP site to be the binding pocket. As introduced in chapter 2, 
AP site can serve as a chemically stable binding cavity in a probe DNA, and provide a target 
nucleobase in the opposite position after hybridization with the target DNA strand. The AP 
site is hydrophobic and allows a direct contact of the small ligand to target nucleobase via 
hydrogen bonding, where the ligand is further stacked with two nucleobases flanking the AP 
site. This makes AP site a suitable binding location in the duplex.
81
 
In fact, some ligands have been already proved to have useful affinity and selectivity for 
target nucleobases opposite the AP sites, including cytosine selective 
2-amino-7-methyl-1,8-naphthyridine (AMND
85,86
), guanine selective 2-amino-6, 
7-dimethyl-4-hydroxypteridine
87
, adenine selective alloxazine
88
 and thymine selective 
amiloride
89
 (Figure 3-2). All of these ligands show a complexation induced fluorescent signal, 
and SNP genotype of samples can be clearly distinguished by binding with ligands. 
 
 
Figure 3-2. AP site-binding ligands developed by our group with specific nucleobase selectivity. 
 
This method needn’t to modify the target and/or probe DNA strands, and measured 
easily by fluorescence spectrophotometer, so as to be cost effective. In addition, the 
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measurement can be carried out rapidly without controlling a precise temperature, which is 
great advantageous in practical use. 
 
3-1-3. Insufficient of AMND for C selective detection 
Focus on one of the C selective ligands—AMND, we realized it was insufficient of the 
selectivity between pyrimidine C and T. Indeed, the difference in the binding affinity of 
AMND derivatives for C over T is only two- or three-fold.
74,81
 The estimated value of binding 
affinity for C was 1.5 M in previous literature 86. As shown in Figure 3-3, the proposed 
hydrogen bonding of AMND can be formed not only with C, but also with T (two possible 
patterns). Therefore, a better exclusive selective ligand for C over T is needed to be 
developed. 
 
Figure 3-3. Proposed binding modes of AMND with C and T (two possible patterns).
74
 
 
 
3-2. Design strategy of CF3-AMND 
Our design strategy is straight forward and simple. Since the protonation at the N8 
position of AMND is feasible, which is preferable for formation of a fully complementary 
hydrogen bonding to T, we proposed to add a strong electron withdraw group to the 
naphthyridine ring. 
The position of CF3 group was calculated by computer before synthesizing compound. 
(Data not shown.) 
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3-3. Experimental 
3-3-1. Materials and experiments 
CF3-AMND has been synthesized and purified by Dr. Takehiro Seino, who was a 
previous member of our group. He has reported CF3-AMND in his doctor’s thesis, but more 
detail information of properties about this ligand is still lack of research. 
 
Synthesis of CF3-AMND
74,90
 
2,6-Diaminopyridine (1.1 g, 10.5 mmol) in phosphoric acid (50 mL) were added to 
1,1,1-trifluoro-2,4-pentanedione (1.6 g, 10.2 mmol) and the reaction mixture was stirred at 
90°C for 26 h. After neutralization with NaOH, the mixture was filtered. The brown residue 
was extracted three times with 200 mL of CHCl3 each time and the organic phase was dried 
over Na2SO4. The solvent was evaporated in vacuo to give the mixture of CF3 
substituent-modified AMND molecules at 5 position and 7 position. Mixture was dissolved in 
10 mL of chloroform, and filtrated. Filtrate was evaporated, dissolved in 20 mL of ethyl 
acetate, and 2 mL of HCl (0.1 M) was dropped in the solution. Filtration of the residue gave 
CF3-AMND as pale yellow needle (25 mg, 0.11 mmol, 1.1 %). 
1H NMR (DMSO-d6, 600 MHz):  = 8.17 (d, 1H, J = 11 Hz), 7.65 (s, 1H), 7.08 (d, 1H, 
J = 11 Hz), 2.68 (s, 3H). HRMS (ESI) for C10H8N3F3: calcd: ([M +H]
+
), 228.0743; found, 
228.0742. 
 
Materials 
DNA sequences 
5’-GCTCCTCTGGXGCCCTCGACG-3’ (X = dSpacer), (260 = 176200 M
-1
cm
-1
) 
5’-GCTCCTCTGGGGCCCTCGACG-3’ (260 = 185440 M
-1
cm
-1
) 
3’-CGAGGAGACCCCGGGAGCTGC-5’ (260 = 208440 M
-1
cm
-1
) 
3’-CGAGGAGACCTCGGGAGCTGC-5’ (260 = 208880 M
-1
cm
-1
) 
3’-CGAGGAGACCACGGGAGCTGC-5’ (260 = 213300 M
-1
cm
-1
) 
3’-CGAGGAGACCGCGGGAGCTGC-5’ (260 = 210960 M
-1
cm
-1
) 
 
All of the DNA samples were custom synthesized and HPLC purified (>97%) by Nihon 
Gene Research Laboratories Inc. (Sendai, Japan). The extinction coefficients at 25C were 
calculated at 260 nm for each strand
63
, which was shown in bracket above. 
The other reagents were commercially available analytical grade and were used without 
further purification. Water was deionized (18.0 M cm specific resistance) by an Elix 5 UV 
Water Purification System and a Milli-Q Synthesis A10 system (Millipore Corp., Bedford, 
MA). 
 
 
Instruments 
Fluorescence measurement: Fluorescence spectra were measured with a JASCO model 
FP-6500 spectrofluorophotometer equipped with a thermoelectrically temperature-controlled 
60 
 
cell holder (Japan Spectroscopic Co. Ltd., Tokyo, Japan). Fluorescence measurements were 
carried out at 20C using a 3  3 mm quartz cell. Excitation wavelength was set at 346 nm for 
CF3-AMND, and 350 nm for AMND. 
UV measurement: JASCO model V-570 spectrophotometer. 
 
 
Preparation of stock solutions 
DNA solutions: The concentrations of DNAs were determined from the molar extinction 
coefficients at 260 nm. Stock solutions were prepared with miliQ water to 250 M and stored 
at 4C. 
Buffer solution: Stock solution was prepared in 100 mL miliQ water and containing 
sodium cacodylate (1.071g, 50 mM), NaCl (2.935g, 500 mM), EDTA (0.187g, 5.0 mM), and 
stored at 4C. When applied it into tubes, it was 5 times diluted, which made the standard 
buffer solution’s concentration as follows: [sodium cacodylate] = 10 mM, [NaCl] = 100 mM, 
[EDTA] = 1.0 mM. 
Buffer solutions at various pH: Prepare sodium cacodylate solution and NaCl/EDTA 
solution separately. The amount of NaCl/EDTA is as two times as pH 7.0 buffer solution. And 
sodium cacodylate (2.14g, 100 mM) in miliQ water, adjusted with HCl or NaOH to the total 
volume as 100 mL. When applied them to samples, combine the two kinds of solutions and 
will give out the concentration as follows: [sodium cacodylate] = 10 mM, [NaCl] = 100 mM, 
[EDTA] = 1.0 mM, pH various. 
 
In Chapter 3, unless otherwise mentioned, all measurements were performed in 
standard buffer solution: 10 mM sodium cacodylate buffer solutions (pH 7.0) containing 
100 mM NaCl and 1.0 mM EDTA. Before measurements, the sample solutions were 
annealed as follows: heated at 75C for 10 min, and gradually cooled to 5C (3C/min), after 
which the solution temperature was raised again to 20C. 
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3-3-2. Determination of binding constants obtained from fluorescence titration. 
The changes in fluorescence intensity of the ligand were monitored as a function of the 
concentration of DNA duplex. The resulting titration curve was analyzed by nonlinear 
least-squares regression based on a 1:1 binding isotherm
65
:  
  F / F0 = {1 + kK11[D]}/{ 1 + K11[D]}  (1) 
where F and F0 are the observed fluorescence intensities of amiloride in the presence and 
absence of duplexes, respectively, and k (= k11/kL) represents the ratio of proportionality 
constants connecting the fluorescence intensities and concentrations of the molecules (1:1 
complex: k11, free ligand: kL). The concentration of the free duplex, [D], can be related to 
known total concentrations of the duplex (D0) and ligand (L 0), by the following equation: 
  D0 = [D] + { L 0K11[D]}/{1 + K11[D]}  (2) 
Together, eqs. (1) and (2) describe the system. 
 
3-3-3. Salt dependence of the binding constants
74,91
 
The effect of different NaCl concentrations on the 1:1 binding constants (K11) of 
CF3-AMND to C and T was examined at 20
 o
C (pH 7.0) by fluorescence titration experiments, 
and analyzed according to the polyelectrolyte theory proposed by Record et al.
91
. The 
observed salt dependence of the binding constants is explained by eq. (3). 
 log K11/ log [Na
+
] = Z = SK   (3) 
where Z is the apparent charge on the ligand and  (0.88 for B-type DNA) is the proportion 
of counterions associated with each DNA phosphate group. The slope (SK) of the plot, which 
is equivalent to the number of counterions released from the duplex upon ligand binding, was 
obtained from the regression lines of best linear least squares fit, by which the values of Z 
were estimated.  
 
3-3-4. Analysis of PCR products 
Asymmetric PCR was performed as described in the literature
 
81. After PCR 
amplification, an aliquot (40 L) of PCR products was buffered to pH 5.5 with 100 mM 
sodium cacodylate. Then, CF3-AMND (0.1 M) and a 20-mer AP site-containing probe DNA 
(2.0M; for sense strand analysis; 5’-CCT ACG CCA XCA GCT CCA AC -3’, for antisense 
strand analysis; 5’-GTT GGA GCT GXT GGC GTA GG-3’, X = AP site; dSpacer (a 
tetrahydrofuranyl residue)) were added. 
Fluorescence spectra of the resulting solutions (50 L) were then measured at 20C with 
FP-6500 spectrofluorophotometer equipped with the thermoelectrically 
temperature-controlled cell holder using 3  3 mm quartz cells. 
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3-4. Results and discussion 
3-4-1. Selectivity of CF3-AMND for receptor nucleobase’s type 
First, we examined the selectivity of CF3-AMND toward different kinds of target 
nucleobases (5’-GCT CCT CTG GXG CCC TCG ACG-3’/ 3’-CGA GGA GAC CNC GGG 
AGC TGC-5’, X = dSpacer, N = A, G, T or C). As shown in Figure 3-4, the addition of a 
fully-matched DNA duplex (X/N = G/C) without AP sites does not cause of any fluorescence 
quenching to CF3-AMND, indicating negligible intercalative binding of CF3-AMND. 
Also, almost no response can be observed for A, G and T in the AP site containing DNA 
duplexes. In contrast, significant fluorescence quenching is observed for C, where the 
fluorescence intensity at 403 nm decreases by as much as 75%. 
 
 
Figure 3-4. Fluorescence spectra of CF3-AMND to the target nucleobase in 21-mer AP site-containing 
DNA duplexes. 
[CF3-AMND] = 1 M, [DNA duplex] = 5 M , buffer, pH 7.0, 20C, Excitation: 346 nm. 
 
The high selectivity for C is consistent with the results observed for UV-visible 
absorption spectral changes (Figure 3-5). The absorption intensity of CF3-AMND 
remarkably decreases upon addition of the AP site-containing DNA duplexes carrying C 
whereas the absorption changes are slight for fully-matched DNA duplexes and AP 
site-containing DNA duplexes carrying the G, A, or T target. 
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Figure 3-5. UV-visible absorption spectra of CF3-AMND in the absence and presence of 21-mer AP 
site-containing DNA duplex. 
[CF3-AMND] = 10 M, [DNA duplex] = 10 M , buffer, pH 7.0, 20C. 
 
 
3-4-2. Determination of the binding affinity 
The binding affinity of CF3-AMND to target nucleobases opposite the AP site was 
examined by fluorescence titration experiments. Fluorescence quenching response of 
CF3-AMND (1.0 μM) was monitored upon addition of AP site-containing DNA duplexes in 
the concentration range from 0 to 7.0 μM (Figure 3-6). The resulting titration curves (Figure 
3-7) were well analyzed by non-linear least-squares regression based on a 1:1 binding model 
and the binding constant (K11) for C was determined as (7.1 ± 0.2) × 10
5
 M
−1
 (n = 3) by three 
times of independent experiments (Figure 3-8). Since the present concentration condition 
was not suitable for accurate determination of K11 for T, A, and G due to the weak binding, 
K11 values for these nucleobases were independently obtained in the high concentration 
conditions ([CF3-AMND] = 10 μM, [DNA duplexes] = 0-70 μM; Figure 3-9). 
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Figure 3-6. Fluorescence response of CF3-AMND (1.0μM) to C in 21-mer AP site-containing DNA 
duplexes. 
Other solution conditions are the same as given in Figure 3-4. 
 
 
Figure 3-7. Fluoresence titration curves for the binding of CF3-AMND to the target nucleobases. 
[CF3-AMND] = 1 M, [DNA duplex] = 0, 0.5, 0,75, 1.0, 1.25, 1.5, 3, 5, 7 M, buffer, pH 7.0, 20C, 
Excitation: 346 nm, Analysis:403 nm. 
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Figure 3-8. Fluorescence titration curves for the binding of CF3-AMND to C (Three times of independent 
experiments). Other solution conditions are the same as given in Figure 3-7. 
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Figure 3-9. Fluoresence titration curves for the binding of CF3-AMND to T (Three times of independent 
experiments). Other solution conditions are the same as given in Figure 3-7. 
 
Significantly, the binding constant for C is found to be more than 50-fold larger than 
those for the other three nucleobases (K11/10
5
 M−1 (n = 3): T, 0.14 ± 0.016; G, 0.16 ± 
0.029; A, <0.10). Such a difference in the binding constants for C over T (K11 (C)/ K11 (T)) is 
much superior to those of the C-binding ligands developed previously.
81,84,92,93
 These results 
clearly show that CF3-AMND shows the strongest binding to C with high selectivity. 
 
Then, the binding affinity of parent AMND was determined by fluorescence titration 
experiment in the same way. The binding constant is (5.4 ± 0.5) × 10
6
 M−1 (n = 3) for C, and 
(1.3 ± 0.1) × 10
6
 M−1, (n = 3) for T, which leads to the relatively low selectivity of AMND 
for C over T (K11 (C)/ K11 (T) = 4.2) compared to CF3-AMND. 
 
  K11 (n = 3) C   T  K11(C)/K11(T) 
AMND /10
6
M
-1
 5.35  0.46 1.29  0.06 4.2 
CF3-AMND /10
5
M
-1
 7.05  0.16 0.142  0.016 51 
Table 3-1. List of binding constants of AMND/CF3-AMND to the target nucleobases C and T. 
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3-4-2. Effect of pH 
Since 2-amino-1,8-naphthyridine derivatives can bind to the pyrimidine nucleobases in 
their protonated states,
81,84,92,93
 we examined the pH dependence of the absorption spectra of 
CF3-AMND to determine the pKa value and it was determined as 5.1 (Data not shown). The 
decrease in pKa compared to the parent AMND (pKa = 6.8)
81
 is ascribed to the increase in the 
acidity of the aza-nitrogen of the AMND ring by attaching the CF3 group. Thus, almost all of 
the CF3-AMND molecules are in a neutral form at pH 7.0 in solution. However, in order to 
form hydrogen bonding with C or T, the protonation of CF3-AMND is necessary. This is 
probably the reason for the binding affinity of CF3-AMND to C or T is smaller than that of 
AMND at pH 7.0. 
We found that the binding affinity of CF3-AMND to C is remarkably increased under the 
acidic solution condition with pH lower than 7.0 (Figure 3-10). Significantly, the K11 value at 
pH 5.5 is (1.3 ± 0.1) × 10
7
 M−1 (n = 3), which is two orders of magnitude larger than that at 
pH 7.0. The observed increase in the affinity can be explained by the increased amount of the 
N1 protonated CF3-AMND species suitable for C-binding at pH 5.5. We did not do any of the 
experiments in the pH range lower than 5.0 considering the possible protonation of 
nucleobases. Importantly, high selectivity of CF3-AMND for C is maintained at pH 5.5 
(Figure 3-11), where the value of K11 (C)/ K11 (T) is 58-fold. Moreover, CF3-AMND shows 
high selective response for C compared to T at pH 5.5 regardless of the nucleobases flanking 
the AP sites in the DNA duplexes (Figure 3-12). Therefore, CF3-AMND can work as an 
effective and versatile ligand for detection of the C-related single-base mutation in DNAs. 
 
Figure 3-10. pH dependence of the quenching efficiency of CF3-AMND (1.0 M) upon binding to the 
target nucleobase (C, red; T, blue; G, green; A, black) in 21-mer AP site-containing DNA duplexes (1.0 
M). 
Quenching efficiency (%) was calculated by (F0-F)/F  100, where F and F0 denote the fluorescence 
intensities of CF3-AMND in the presence and absence of DNA duplexes, respectively. 
Error bars represent the standard deviations obtained from three independent experiments. 
[CF3-AMND] = 1 M, [DNA duplex] = 1 M, buffer, pH = 5.0~8.0, 20C, 33 mm quartz cell, Ex band: 3 
nm, Em band: 5 nm, Excitation: 346 nm, Analysis: 403 nm. 
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Figure 3-11. Fluorescence titration curves for the binding of CF3-AMND (1.0 M) to 21-mer AP 
site-containing DNA duplexes, obtained in solutions buffered to pH 5.5 (10 mM sodium cacodylate) 
containing 100 mM NaCl and 1.0 mM EDTA. 
The changes in the fluorescence intensities at 403 nm were analyzed based on a 1:1 binding isotherm 
model. 
F and F0 denote the fluorescence intensities of CF3-AMND in the presence and absence of DNA duplexes, 
respectively. 
[CF3-AMND] = 1 M, [DNA duplex] = 0, 0.5, 0.75, 1.0, 1.25, 1.5, 3, 5, 7 M, buffer, pH = 5.5, 20C, 33 
mm quartz cell, Ex band: 3 nm, Em band: 5 nm, Excitation: 346 nm, Analysis: 403 nm. 
 
 
 
K11 (n = 3) C T K11(C)/K11(T) 
AMND at pH 7.0 / M
-1
 (5.35  0.46)106 (1.29  0.06)106 4.2 
CF3-AMND at pH 7.0 / M
-1
 (7.05  0.16)105 (1.42  0.16)104 51 
CF3-AMND at pH 5.5 / M
-1
 (1.30  0.13)107 (2.23  0.08)105 58 
Table 3-2. List of binding constants of AMND/CF3-AMND to the target nucleobases C or T at pH 7.0 and 
pH5.5. 
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Figure 3-12 Effect of flanking nucleobases on the fluorescence quenching efficiency of CF3-AMND (0.5 
M) to C (gray bars) and T (white bars) in the 21-mer AP site-containing DNA duplexes (1.0 M; 5’-GCT 
CCT CTG WXW’ CCC TCG ACG-3’/3’-CGA GGA GAC ZNZ’ GGG AGC TGC-5’, X = AP site (Spacer 
C3) or G, N = C, or T). W, W’ represent the nucleobases flanking the AP site and Z, Z’ represent 
complementary nucleobases flanking the target nucleobase; WXW’/ZNZ’ = 1) TXT/ANA, 2) GXT/CNA, 
3) CXT/GNA, 4) AXT/TNA, 5) TXG/ANC, 6) CXG/GNC, 7) AXG/TNC, 8) GXG/CNC, 9) TXC/ANG, 
10) GXC/CNG, 11) CXC/GNG, 12) AXC/TNG, 13) TXA/ANT, 14) GXA/CNT, 15) CXA/GNT, 16) 
AXA/TNT. Other solution conditions are the same as those given in Figure 3-11. Quenching efficiency (%) 
was calculated by (F0-F)/F 100, where F and F0 denote the fluorescence intensities of CF3-AMND in the 
presence and absence of DNA duplexes, respectively.  Excitation, 346 nm. Analysis, 403 nm. Temperature, 
20C. 
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3-4-3. Determination of apparent charge (Z) 
Protonated CF3-AMND can bind to C and T at the AP site, as revealed by the 
examination of the salt dependence of the binding constants K11 based on Record’s 
polyelectrolyte theory
91
. The binding constants of CF3-AMND for C and T were determined 
at different salt concentrations using fluorescence titration experiments (Figure 3-13). K11 
values for C and T remarkably decrease as the salt concentration increases (Table 3-3). The 
estimated apparent charges (Z) of CF3-AMND were estimated as 1.47 and 1.02 when binding 
to C and T, respectively, as obtained from the linear regression analysis of a double 
logarithmic plot of K11 versus the Na
+
 concentration (Figure 3-14). 
These results indicate that the protonation of the bound CF3-AMND at pH 7.0 would be 
facile compared to the protonation in the free state, and this is consistent with the previously 
reported results.
81,84,92,93
 
 
 
Figure 3-13. Fluorescent titration experiments at different salt concentrations for (A) cytosine, and (B) 
thymine. 
 
 
 [Na
+
] = 60 mM
a)
  [Na
+
] = 110 mM
b)
  [Na
+
] = 210 mM
a)
  [Na
+
] = 310 mM
a)
  
C  2.1 ( 0.1)  106  7.2 ( 0.2)  105  3.9 ( 0.3)  105  1.3 ( 0.2)  105  
T  4.0 ( 0.1)  104  1.4 ( 0.2)  104  1.2 ( 0.1)  104  8.7 ( 0.4)  103  
Table 3-3. Binding constants of CF3-AMND to C and T at different salt concentrations 
a) Errors are the fitting errors. 
b) Errors are the standard deviations obtained from three independent experiments. 
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Figure 3-14. Salt dependence of the binding constants (K11) of CF3-AMND to C (upper) and T (lower). 
The obtained linear equation: y = 4.70 1.29 x (r = 0.9859) for C, y = 3.460.898 x (r = 0.9859) for T. 
Calculation procedure of apparent charge: 
δ log K11/δ log [Na
+
] = −Zψ = SK 
Z: the apparent charge on the ligand; ψ: the proportion of counterions associated with each DNA phosphate 
group (0.88 for B-type DNA); SK: the slope of the plot, which is equivalent to the number of counterions 
released from the duplex upon ligand binding. 
Thus, for C: Z= -SK/ ψ = 1.29/0.88 = 1.47; for T: Z= -SK/ ψ = 0.898/0.88 = 1.02  
 
 
3-3-4. Effect of the type of binding site 
    We tried to apply other kinds of active sites instead of AP site for the binding event. 
However, only moderate selectivity for C can be obtained by gap site, and almost no 
selectivity by bulge site. This result indicates our ligand is only applicable for AP site as the 
active binding site, which is a restriction to widely apply this ligand. 
 
DNA sequences 
AP site:   5’-GCTCCTCTGGXGCCCTCGACG-3’, X = AP-site (dSpacer); 
3’-CGAGGAGACCNCGGGAGCTGC-5’, N = C, T, G or A 
Gap site:  5’-GCTCCTCTGG-3’ 5’-GCCCTCGACG-3’ 
3’-CGAGGAGACCNCGGGAGCTGC-5’, N = C, T, G or A 
Bulge site:  5’-GCTCCTCTGGGCCCTCGACG-3’ 
3’-CGAGGAGACCNCGGGAGCTGC-5’, N = C, T, G or A 
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Fig. 3-15. Fluorescence spectra by using different kinds of binding sites; and schematic drawing of these 
sites . 
 
 
 
3-4-5. Explanation of the improved selectivity of CF3-AMND compared to 
AMND 
As shown in Figure 3-16, CF3-AMND binds to C and T in N1 and N8-protonated forms, 
respectively. Although further studies such as NMR analysis are required to examine the 
binding behaviors in detail, it is conceivable that the observed high selectivity of CF3-AMND 
for C over T (Figure 3-7) arises from more favorable protonation at the N1 position than the 
N8 position due to the electron-withdrawing effect of the CF3 group, which then enables the 
effective pseudo-base pairing with C through hydrogen bonding. 
 
Figure 3-16. Possible binding modes of AMND or CF3-AMND with C and T (two possible patterns).
74
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3-4-6. Application of CF3-AMND to C-related singlebase mutation in K-ras 
gene 
CF3-AMND was applied to the analysis of singlebase mutation in 107-mer DNAs (K-ras 
gene; codon 12, sense strand)
81
 amplified by asymmetric PCR. Figure 3-16 shows 
fluorescence responses of 0.1 μM CF3-AMND to the amplified DNAs carrying different 
target nucleobases measured at 5 °C in a solution buffered to pH 5.5 containing 2.0 μM AP 
sitecontaining probe DNA (5’-CCT AC  CCA X CA  CT CCA AC-3’, X  = AP site 
(dSpacer)). As is clearly seen, CF3-AMND exhibits significant fluorescence quenching for 
C-containing DNA sequences whereas moderate responses are observed for DNAs containing 
G, T, and A targets. Therefore, CF3-AMND is applicable to highly selective detection of C 
compared to other nucleobases in PCR products, which will facilitate the accurate analysis of 
C-related single-base mutation in practical use. 
 
 
Figure 3-16. Analysis of a single-base mutation in 107-mer DNAs (K-ras gene, codon 12, sense strand) 
amplified by PCR, measured in solutions buffered to pH 5.5 (100 mM sodium cacodylate) containing 2.0 
μM AP site-containing probe DNA and 0.1 μM CF3-AMND. Quenching efficiency (%) was calculated by 
(F0 − F)/F × 100, where F and F0 denote the fluorescence intensities of CF3-AMND in the presence and 
absence of DNA duplexes, respectively. Excitation: 346 nm. Analysis: 403 nm. Temperature: 5 °C. 
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3-5. Conclusion 
In summary, we successfully developed CF3-AMND as a C-specific binding ligand 
based on AMND. It shows highly selective binding to C in AP site-containing DNA duplexes. 
The introduction of a CF3 substituent into the parent AMND significantly improved the 
binding selectivity for C. We expect that high C-selectivity of CF3-AMND will be able to 
provide accurate analysis of C-related single-base mutation in DNAs.  
On the other hand, we noted that the binding affinity of CF3-AMND to C is relatively 
moderate at the physiological pH condition, and not applicable by using other type of binding 
sites. Therefore, further efforts to conquer these disadvantages are needed towards practical 
gene analysis.  
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Chapter 4: Development of peptide nucleic acid-thiazole orange conjugates for 
discrimination of terminal mismatches in DNA/RNA 
 
4-1. Introduction 
4-1-1. Routine method for the detection of terminal mismatch 
As introduced in last chapter, mismatches of DNA/RNAs will be formed when 
mutations occur, and study of mismatches is clinically important for diagnostics, prognostics, 
risk assessment and disease prevention. Such as SNPs, where a single nucleobase mismatch 
formed, will relate to diseases. (ref. introduction in Chapter 3) 
Usually, detection of mismatches relies on the method based on the thermal stability of 
duplex hybridization, and the hybridization property can be evaluated by determining their 
melting temperature (Tm). The melting temperature is defined as the temperature at which 50% 
of the DNA strands are in the random coil or single-stranded state; thus meanwile, 50% of the 
DNA strands and their perfect complements are in duplex. It’s the temperature of a middle 
state between DNA single strands and duplexes.
94
 
However, Tm values, measured from melting temperature experiments, are different by 
only a few degrees (0.5~3C)95 between perfectly matched duplexes and terminal 
mismatched ones. 
Particularly, when the mismatches happen at the terminal positions of DNA/RNAs’ 
strand, it’s more difficult to be detected than at the internal positions. This is because a 
mismatch at internal position of DNA/RNA duplex is easier to be destabilized than a terminal 
mismatch in general, so as to be easier tested by melting temperature experiments.
96
 It 
becomes much more difficult to be discriminated for short duplexes.
97 
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4-1-2. DNA-TO and PNA-TO ligands for the detection of (terminal) mismatch 
Ulysse Asseline and coworkers have proposed a method by measuring fluorescent signal 
for the detection of terminal mismatch. They synthesized a series of complementary 
oligo-DNA strands conjugated with thiazole orange (TO) as fluorescent markers. To the target 
single nucleobase, if mismatch forms, the fluorescence response will be stronger (Figure 4-1). 
Thus the mismatches can be detected successfully.
98 
However, in the result they have shown, it was only related to the 3
rd
 or 4
th
 mismatches 
counted from the terminal of DNA strand, which are not so much the terminal positions. And 
the need of modification of probe DNA makes it inconvenient and time consuming, 
especially when the DNA strand is longer. 
 
 
 
Figure 4-1. DNA sequences used in developing ODN-TO’ conjugate experiments for terminal mismatch 
detection.
98 
 
 
 
Instead of oligo-DNA strands, peptide nucleic acids (PNAs) are often used for its better 
stability compared with corresponding DNAs (Thermal stable to hybridize with DNA/RNA 
by lack of electrostatic repulsion; enzymatic stable for not easily recognized by either 
nucleases or proteases).
99,100
 Structurally, PNAs are neutral artificial nucleic acids with 
backbones composed of repeating N-(2-aminoethyl)-glycine units linked by peptide bonds 
(Figure 4-2). 
 
Figure 4-2. Structure of PNA’s backbone 
 
Oliver Seitz and coworkers developed a PNA-TO conjugate for internal mismatch 
detection.
101
 It showed good selectivity between perfect match sequence and the mismatched 
ones (Figure 4-3). 
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Figure 4-3. PNA-TO conjugate for internal mismatch detection.
101
 
 
To combine the results of their research, we realized that the PNA-TO conjugate might 
be a promising candidate for the detection of mismatches at terminal positions. 
 
 
In our group, a series of PNA-TO conjugates has been devoloped recently for siRNA’s 
delivery imaging, even in living cells.
102 
Figure 4-4 shows the possible binding mode of 
PNA-TO to siRNA duplex’s terminal position. Here, PNA unit is synthesized to recognize the 
terminal overhang two nucleobases, and TO unit works as a fluorescence light-up intercalator. 
 
 
Figure 4-4. Possible binding mode of PNA-TO to siRNA duplex’s terminal position (Energy-minimized 
structure by MacroModel ver. 9.0).
102
 
 
Moreover, this AA-TO ligand for the purpose of siRNA’s imaging, also showed a good 
selective fluorescence response for perfect match sequence over terminal mismatched ones 
(Figure 4-5). It indicates the using of PNA-TO would be promising for selective binding to 
the overhang nucleobases. 
However, this result related to only two nucleobases which is obviously not enough for 
the purpose of a single-base mismatch detection. And we showed mutations detection only in 
the internal part of DNA/RNA strands in SNPs so far (ref. Chapter 3). As a supplement, we 
also hope to develop the technique not only related to the internal positions, but also the 
terminal positions. Therefore, method for the detection of a single-base mismatch at terminal 
position of nucleic acids is needed to be developed. 
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Figure 4-5. (A) Sequence of siRNA; (B) Structure of the PNA-TO ligand (AA-TO);  
(C) Fluorescence response for perfect match sequence (TT), and mismatched ones (AA, GG, and CC). 
102
 
 
 
 
4-1-3. Let-7 microRNA family 
The lethal-7 (let-7) gene was first discovered in the nematode Caenorhabditis elegans as 
a key developmental regulator by controling the timing of stem-cell division and 
differentiation, and became one of the first two known microRNAs (the other one is lin-4). 
Let-7 and its family members are highly conserved across species in sequence and function, 
and misregulation of let-7 leads to a less differentiated cellular state and the development of 
cell-based diseases such as cancer.
103
 
Numerous reports have shown that the expression levels of let-7 are frequently low and 
the chromosomal clusters of let-7 are often deleted in many cancers.
104
  Let-7 is expressed at 
higher levels in more differentiated tumors, which also have lower levels of activated 
oncogenes. Therefore, expression levels of let-7 could be prognostic markers in several 
cancers associated with differentiation stages. In lung cancer, for example, reduced 
expression of let-7 is significantly correlated with reduced postoperative survival.
105-107 
However, the detection and describe of the members of let-7 family is a challenge as the 
sequences of members is similar that differ by only a few nucleobases. Such sequences will 
hybridize similarly to the complementary probes and the signal will not be specific anymore. 
Let-7d in the let-7 family, which has been implicated in cocaine addiction and other 
neurological disorders, targets the neural stem cell regulator TLX. Overexpression of let-7d in 
vivo reduced neural stem cell proliferation and promoted premature neuronal differentiation 
and migration.
108 
Thus, development of the detection method for let-7d becomes useful. 
Here, by using the PNA-TO conjugates, we hope that let-7d with a single nucleobase 
mismatch at the 5’- terminal position compared to other let-7 family members can be 
recognized. 
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4-2. Design strategy 
PNA’s backbone is composed of repeating N-(2-aminoethyl)-glycine units linked by 
peptide bonds. Higher thermal stability and specificity than the corresponding DNAs in order 
to make sure it will hybridize with complementary probe smoothly, regardless of its short 
length. TO was chosen as an intercalator in order to stabilize the duplex. In addition, TO can 
act as fluorescence marker to give out a fluorescent signal so as to be measured by 
fluorescence spectrometer. 
Our detection scheme is quite simple. First, put the target strand and probe strand 
together and let the hybridization happen, so as to form a duplex and leave the target terminal 
nucleobases exposed. Then put PNA-TO ligands into the solution. If a perfect match formed 
at the terminal position, it will emit a fluorescent signal. But if mismatches exist, PNA would 
be restricted to recognize the target nucleobases, thus a small signal can be obtained. By this 
process, the selective recognition between match and mismatch sequences can be achieved 
(Figure 4-6). 
Higher ability to discriminate terminal mismatch by giving a stronger fluorescent signal 
is expected compared to the two PNA-TO conjugate
102
, because of the increased number of 
PNA should contribute to stabilize the binding. 
However, we also didn’t chose PNA sequences for more than three nucleobases. It’s 
because an ultra-shot PNA strand is expected more sensitive than the longer ones when 
binding to target strands. They should be easier to be destabilized by mismatches, so as to be 
easier to give out signaling. 
 
 
Figure 4-6. Detection scheme of our PNA-TO ligand for terminal mismatch. 
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4-3. Experimental 
Synthesis procedure of peptide nucleic acid -thiazole orange conjugates (PNA-TO).
102
 
All probes examined in this study were synthesized on an Endeavor 90 peptide 
synthesizer (Apptec, Louisville, KY, USA) based on Fmoc/Bhoc chemistry. Briefly, 
Fmoc-Lys(Alloc)-OH was first loaded onto Rink Amide AM resin and Fmoc/Bhoc-protected 
PNA monomers were then coupled. For pyrene-containing conjugates, pyrene derivative was 
coupled to N-terminal of the PNA-lysine assembly directly or through a glycine spacer. The 
assembly on the resin was performed by repetitive cycles of Fmoc deprotecting (20% 
piperidine in DMF), coupling with DIC/HOBt activation, and capping (acetic 
anhydride/pyridine). The completion of the coupling reactions was confirmed by the Kaiser 
test. After the selective deprotection of the Alloc group by treating with 
tetrakis(triphenylphosphine) palladium (0) and dimethylamine borane in dichloromethane, 
carboxylate-terminated butyl spacer-containing TO derivative
109
 was coupled to the -amino 
group of Lys. After the Fmoc group was deprotected, deprotection of Bhoc groups in PNA 
nucleotides and cleavage from the resin were carried out using a mixture of trifluoroacetic 
acid (TFA)/triisopropylsilane/water (95/2.5/2.5). After the resulting solution was filtered to 
remove the resin, the probes were then precipitated in cold diethyl ether. The crude products 
were purified by a reverse-phase HPLC system (pump, PU-2086 Plus x2; mixer, MX 2080-32; 
column oven, CO-1565 (40C); detector, UV-2070 plus and UV-1570M (Japan Spectroscopic 
Co. Ltd., Tokyo, Japan)) equipped with a C18 column (Inertsil ODS3: GL Sciences Inc., 
Tokyo, Japan) using a gradient of water/acetonitrile containing 0.05% TFA. All probes used 
in this study were verified for 90% by MALDI-TOF-MS (4800 Plus MALDI TOF/TOF 
analyzer: AB Sciex, Tokyo, Japan). 
 
A2 (AAA-C2-TO): MALDI-TOF-MS for C60H71N26O8S [M]
+
 ; calcd 1315.57, found 
1315.48.  
A4 (AAA-C4-TO): MALDI-TOF-MS for C62H76N26O8S [M]
+
 ; calcd 1343.60, found 
1343.92.  
A6 (AAA-C6-TO): MALDI-TOF-MS for C64H79N26O8S [M]
+
 ; calcd 1371.63, found 
1371.92.  
C6 (CCC-C6-TO): MALDI-TOF-MS for C61H79N20O11S [M]
+
 ; calcd 1299.60, found 
1299.53.  
Py-C4 (Pyrene-CCC-C4-TO): MALDI-TOF-MS for C78H86N21O13S [M]
+
 ; calcd 1556.64, 
found 1557.13.  
Py-TCT-TO (Pyrene-TCT-C4-TO): MALDI-TOF-MS for C80H88N19O15S [M]
+
 ; calcd 
1586.64, found 1587.24.  
 
These PNA-TO ligands were dissolved into water to prepare the stock solutions. Stock 
solutions of pyrene-containing probes were prepared using water or water/DMSO (for 
Py-TCT-TO only) mixtures. These stock solutions were kept at 4C in the dark before their 
use. Sample solutions of pyrene-containing probes used for the experiments contain a small 
amount of these organic solvents (< 0.2%). 
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DNA and RNA sequences 
5’-TTT: 5’-TTTGACCTAGTAGGCTGC-3’ (260 = 171320 M
-1
cm
-1
) 
5’-ATT: 5’-ATTGACCTAGTAGGCTGC-3’ (260 = 176940 M
-1
cm
-1
) 
5’-TAT: 5’-TATGACCTAGTAGGCTGC-3’ (260 = 176640 M
-1
cm
-1
) 
5’-TTA: 5’-TTAGACCTAGTAGGCTGC-3’ (260 = 177200 M
-1
cm
-1
) 
3’-TTT: 5’-GACCTAGTAGGCTGCTTT-3’ (260 = 171800 M
-1
cm
-1
) 
3’-ATT: 5’-GACCTAGTAGGCTGCTTA-3’ (260 = 178140 M
-1
cm
-1
) 
3’-TAT: 5’-GACCTAGTAGGCTGCTAT-3’ (260 = 177120 M
-1
cm
-1
) 
3’-TTA: 5’-GACCTAGTAGGCTGCATT-3’ (260 = 176800 M
-1
cm
-1
) 
 
5’-GGG:  5’-GGGGACCTAGTAGGCTGC-3’ (260 =179140 M
-1
cm
-1
) 
5’-CGG:  5’-CGGGACCTAGTAGGCTGC-3’ (260 = 175060 M
-1
cm
-1
) 
5’-GCG:  5’-GCGGACCTAGTAGGCTGC-3’ (260 =175140 M
-1
cm
-1
) 
5’-GGC:  5’-GGCGACCTAGTAGGCTGC-3’ (260 = 175140 M
-1
cm
-1
) 
3’-GGG:  5’-GACCTAGTAGGCTGCGGG-3’ (260 = 179620 M
-1
cm
-1
) 
3’-CGG:  5’-GACCTAGTAGGCTGCGGC-3’ (260 = 175140 M
-1
cm
-1
) 
3’-GCG:  5’-GACCTAGTAGGCTGCGCG-3’ (260 = 175620 M
-1
cm
-1
) 
3’-GGC:  5’-GACCTAGTAGGCTGCCGG-3’ (260 = 176360 M
-1
cm
-1
) 
 
No overhang: 5’-GACCTAGTAGGCTGC-3’ (260 = 147040 M
-1
cm
-1
) 
Probe:      3’-CTGGATCATCCGACG-5’ (260 = 144000 M
-1
cm
-1
) 
 
let-7a:  5’- UGAGGUAGUAGGUUGUAU AGUU-3’ (260 = 244510 M
-1
cm
-1
) 
let-7b:  5’- UGAGGUAGUAGGUUGUGUGGUU-3’ (260 = 237310 M
-1
cm
-1
) 
let-7c:  5’- UGAGGUAGUAGGUUGUAUGGUU-3’ (260 = 240730 M
-1
cm
-1
) 
let-7f :  5’- UGAGGUAGUAGAUUGUAUAGUU-3’ (260 = 246670 M
-1
cm
-1
) 
let-7d:  5’- AGAGGUAGUAGGUUGCAUAGU-3’ (260 = 234650M
-1
cm
-1
) 
let-7e:  5’- UGAGGUAGGAGGUUGUAUAGU-3’ (260 = 234290 M
-1
cm
-1
) 
let-7g:  5’- UGAGGUAGUAGUUUGUACAGU-3’ (260 = 229780 M
-1
cm
-1
) 
let-7i:   5’- UGAGGUAGUAGUUUGUGCUGU-3’ (260 = 221510 M
-1
cm
-1
) 
DNA probe:   3’-CCATCATCCTTCGTATCA-5’ (260 = 172080 M
-1
cm
-1
) 
RNA probe:  3’-CCAUCAUCCUUCGUAUCA-5’ (260 = 177580 M
-1
cm
-1
) 
 
 
All of the DNA samples were custom synthesized and HPLC purified (>97%) by Nihon 
Gene Research Laboratories Inc. (Sendai, Japan). RNAs were custom synthesized and PAGE 
purified (>97%) by Sigma-Genosys (Hokkaido, Japan). The extinction coefficients at 25C 
were calculated at 260 nm for each strand 
63
, which was shown in bracket above. 
Rink Amide AM resin, Fmoc-protected amino acid derivative were purchased from 
Aapptec (Luisville, KY, USA). 
Fmoc/Bhoc protected PNA monomers were purchased from ASM Research Chemicals 
(Hannover, Germany). 
The other reagents were commercially available analytical grade and were used without 
further purification. Water was deionized (18.0 M cm specific resistance) by an Elix 5 UV 
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Water Purification System and a Milli-Q Synthesis A10 system (Millipore Corp., Bedford, 
MA). 
 
 
Instruments 
Fluorescence measurement: Fluorescence spectra were measured with a JASCO model 
FP-6500 spectrofluorophotometer equipped with a thermoelectrically temperature-controlled 
cell holder (Japan Spectroscopic Co. Ltd., Tokyo, Japan). Fluorescence measurements were 
carried out at 20C using a 3  3 mm quartz cell. Excitation wavelength was set at 514 nm for 
PNA-TO ligands. 
UV measurement: JASCO model V-570 spectrophotometer. 
 
 
Preparation of stock solutions 
DNA and RNA solutions: The concentrations of DNAs were determined from the molar 
extinction coefficients at 260 nm. Stock solutions were prepared with miliQ water to 250 M 
or 100 M and stored at 4C for DNA; -20C for RNA. 
Buffer solution: Stock solution was prepared in 100 ml miliQ water and containing 
sodium cacodylate (1.071g, 50 mM), NaCl (2.935g, 500 mM), EDTA (0.187g, 5.0 mM), and 
stored at 4C. When applied it into tubes, it was 5 times diluted, which made the standard 
buffer solution’s concentration as follows: [sodium cacodylate] = 10 mM, [NaCl] = 100 mM, 
[EDTA] = 1.0 mM. 
 
In Chapter 4, unless otherwise mentioned, all measurements were performed in 
standard buffer solution: 10 mM sodium cacodylate buffer solutions (pH 7.0) containing 
100 mM NaCl and 1.0 mM EDTA. Before measurements, the sample solutions were 
annealed as follows: heated at 75C for 10 min, and gradually cooled to 5C (3C/min), after 
which the solution temperature was raised again to 20C. 
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4-4. Results and discussion 
4-4-1. Optimization of PNA-TO conjugates 
4-4-1-1. Abstract 
We carried out a series experiments to determine the most likely useful PNA-TO 
conjugate to recognize terminal mismatches in DNA duplexes. Since the similarity of DNAs 
and RNAs, and the better stability and inexpensive property, we used DNAs for the 
preliminary experiments. For PNA-TO ligands, we first surveyed the selectivity for terminal 
mismatch at both 5’ and 3’ end. Then, we synthesized a series PNA-TO conjugates with 
different lengths of the linker between PNA moiety and TO moiety (A2, A4, and A6), and 
compared the effect of linker’s length to selectivity. Next, we also synthesized a different 
kind of ligand (C6) targeting another type of terminal mismatch, and tried to prove that our 
approach is workable without relationship of the sequence. Finally, we showed a 
demonstration of microRNA’s terminal mismatch recognition. 
 
4-4-1-2. Discrimination ability of PNA-TO for terminal mismatch 
We synthesized A
PNA
-A
PNA
-A
PNA
-(CH2)6-TO (A6) first, and measured fluorescence 
spectra of A6 with or without DNA duplex. As shown in Figure 4-6, the ligand A6 alone has 
almost negligible fluorescence response. However, upon addition of DNA duplexes, strong 
fluorescence signal can be observed. For both 5’ and 3’ ends, selective response for perfect 
match sequence over mismatched sequences can be obtained. And obviously, the 
discrimination ability relates to the mismatch formed position: the fluorescence intensity of 
perfect match sequences are larger than 1
st
 terminal mismatches, followed by 2
nd
 and 3
rd
 
terminal mismatches, and followed by no overhang sequences. 
The N- end of PNA corresponds to 5’ end of DNA, and C- end of PNA corresponding to 
3’ end of DNA. In general, antiparallel forms (two strands with opposite alignments) of 
nucleic acid duplexes are canonical form (Figure 4-7). Interestingly, the result shows 
fluorescence intensity of 5’ end is comparable with 3’ end for perfect match strand in our 
system, which means parallel formation can be formed in this case.  
 
DNA sequences used in this section: 
5’-TTT: 5’-TTTGACCTAGTAGGCTGC-3’ 
5’-ATT: 5’-ATTGACCTAGTAGGCTGC-3’ 
5’-TAT: 5’-TATGACCTAGTAGGCTGC-3’ 
5’-TTA: 5’-TTAGACCTAGTAGGCTGC-3’ 
3’-TTT: 5’-GACCTAGTAGGCTGCTTT-3’ 
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3’-ATT: 5’-GACCTAGTAGGCTGCTTA-3’ 
3’-TAT: 5’-GACCTAGTAGGCTGCTAT-3’ 
3’-TTA: 5’-GACCTAGTAGGCTGCATT-3’ 
No overhang: 5’-GACCTAGTAGGCTGC-3’ 
Probe:      3’-CTGGATCATCCGACG-5’ 
 
 
 
Figure 4-6. (A) Structure of A
PNA
-A
PNA
-A
PNA
-(CH2)6-TO (A6); 
(B) Fluorescence spectra of A6 to DNA duplexes at 5’ ends; 
(C) Fluorescence spectra of A6 to DNA duplexes at 3’ ends. 
[DNA duplex] = [A6] = 200 nM, buffer, pH 7.0, 20C, Sensitivity: medium, Ex band: 3 nm, Em band: 5 nm, 
33 quartz cell, Excitation: 514 nm. 
 
 
 
Figure 4-7. Illustration of antiparallel and parallel form of DNA/PNA-TO duplex 
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4-4-1-3. Effect of the linker’s length in PNA-TO ligands 
In order to investigate the effect of linker’s length in PNA-TO ligands, we further 
synthesized AAA-C2-TO (A2) and AAA-C6-TO (A6). As shown in Figure 4-8, for all 
ligands, selective response for perfect match sequence over mismatched sequences can be 
obtained at 3’ end. And the degree of light-up response, however, depends on the linker’s 
length (A6, A4  A2), suggesting longer linker would be better for the effective fluorescent 
response. The same selectivity and tendency can be observed for 5’ end too (Data not shown). 
 
 
       
Figure 4-8. (A), (B) and (C) Fluorescence spectra of A2, A4, and A6 to DNA duplexes at 3’ ends, 
respectively; (D) Structure of A
PNA
-A
PNA
-A
PNA
-(CH2)6-TO (A6). 
[DNA duplex] = [A2, A4 or A6] = 200 nM, buffer, pH 7.0, 20C, Sensitivity: medium, Ex band: 3 nm, Em band: 
5 nm, 33 quartz cell, Excitation: 514 nm. 
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4-4-1-4. Ligand design for another sequence 
    We wanted to prove the universal of our ligand design strategy. Therefore, we 
synthesized another PNA-TO ligand (Figure 4-9(A)) for different target sequences. The 
linker’s length is determined as 6, so the ligand is CPNA-CPNA-CPNA-(CH2)6-TO (C6). The 
result shows the discrimination ability maintains for perfect match sequence over terminal 
mismatches, irrespective of the type of nucleobases (purine of pyrimidine). This implies the 
ligand design would have flexibility for any kind of terminal sequences, which is a great 
advantageous of our method. 
 
DNA sequences used in this section: 
5’-GGG:  5’-GGGGACCTAGTAGGCTGC-3’ 
5’-CGG:  5’-CGGGACCTAGTAGGCTGC-3’ 
5’-GCG:  5’-GCGGACCTAGTAGGCTGC-3’ 
5’-GGC:  5’-GGCGACCTAGTAGGCTGC-3’ 
3’-GGG:  5’-GACCTAGTAGGCTGCGGG-3’ 
3’-CGG:  5’-GACCTAGTAGGCTGCGGC-3’ 
3’-GCG:  5’-GACCTAGTAGGCTGCGCG-3’ 
3’-GGC:  5’-GACCTAGTAGGCTGCCGG-3’ 
No overhang: 5’-GACCTAGTAGGCTGC-3’ 
Probe:      3’-CTGGATCATCCGACG-5’ 
 
 
Figure 4-9. (A) Structure of C
PNA
-C
PNA
-C
PNA
-(CH2)6-TO (C6); 
(B) Fluorescence spectra of C6 to DNA duplexes at 5’ ends; 
(C) Fluorescence spectra of C6 to DNA duplexes at 3’ ends. 
Other solution conditions are the same as given in Figure 4-6. 
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4-4-1-5. Comparison of the binding selectivity for the target terminal overhang 
sequences with A (purine) and C (pyrimidine) 
    We summarized the data for the ligand A6 and C6, and compared them. For 3’ end, both 
ligands show good selectivity for perfect match sequences, where the fluorescence intensities 
are ca. 40%~60% larger than mismatches. However, the selectivity for 5’ end shoud be 
improved, especially for the 1
st
 terminal mismatches (Figure 4-10; marked with red 
rectangle).  
 
Figure 4-10. Bar figures of normalized fluorescence intensity for (A) A6, and (B) C6. 
Other solution conditions are the same as given in Figure 4-6. 
 
 
The binding affinities have been measured by fluorescent titration experiments, and the 
results are shown in Table 4-1.  
 
K
11 
(n = 3) A6 / 10
6
M
-1
 C6 / 10
6
M
-1
 
5’- perfect match (5’-TTT or 5’-GGG) 4.6  0.1 10.5  2.5 
5’- 1
st
 mismatch (5’-ATT or 5’-CGG) 1.9  0.5 10.7  2.3 
3’-perfect match (3’-TTT or 3’-GGG) 2.6  0.3 7.5  0.9 
3’- 1
st
 mismatch (3’-ATT or 3’-CGG) 1.8  0.1 2.3  0.4 
Table 4-1. Binding constants for A6 and C6 to perfect match sequences and 1
st
 terminal mismatches. (Errors are 
the fitting errors.) 
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4-4-2. Enhancement of the selectivity at 5’- end 
    From the fluorescence spectra of A6 (Figure 4-6) and C6 (Figure 4-9), we noticed the 
response to no overhang strands also existed (5’-GACCTAGTAGGCTGC-3’/ 
3’-CTGGATCATCCGACG-5’). It’s probably come from the nonspecific intercalation of TO 
unit to the DNA duplex, without complementary recognition of PNA unit to the terminal 
target bases. Accordingly, the key to high selectivity for the overhanging nucleobases is to 
suppress such non-selective intercalation.
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    We took the same strategy as ref. 102, which is to introduce pyrene as a cap structure at 
N-terminal of PNA-TO (Py-PNA-TO) because the high propensity of pyrene for - 
stacking can promote the intramolecular stacking of the probe in the absence of target DNAs 
(Figure 4-11). Therefore, it restricts the nonspecific intercalation of TO unit to the stem of 
DNA duplex. Moreover, after binding with the DNA duplex, pyrene will also provide 
terminal stacking interactions which benefit a more stable binding, and a hydrophobic 
environment, which benefit to form hydrogen bonds. 
 
Figure 4-11. The possible initial conformation of Py-PNA-TO 
 
The results are listed in Figure 4-12. The left side figure (B) presents the spectra by 
using C6 (CCC-C6-TO), and the right side figure (C) presents the spectra by using Py-C 
(Pyrene-CCC-C4-TO). Py-C shows an incredibly good selectivity for terminal mismatches, 
regardless of the mismatch formed position. Especially for 1
st
 terminal mismatch, the 
selectivity has been improved as compared to the ligand without pyrene moiety. This means 
pyrene cap is significantly effective in the improvement of binding selectivity for terminal 
mismatches at 5’ end. 
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Figure 4-12. (A) Structure of Pyrene-C
PNA
-C
PNA
-C
PNA
-(CH2)4-TO (Py-C4); 
(B) Fluorescence spectra of C6 to DNA duplexes at 5’ ends; 
(C) Fluorescence spectra of Py-C4 to DNA duplexes at 5’ ends. 
Other solution conditions are the same as given in Figure 4-6. 
 
In fact, we also tried to synthesize the ligand with the linker’s length as C6 
(Pyrene-CCC-C6-TO). However, almost no obviously improvement of selectivity can be 
achieved (Figure not shown). It probably can be explained by considering the possible initial 
conformation of this ligand (Figure 4-11). If the linker’s length increases, it would be longer 
distance between PNA unit and TO unit, so as to be harder to form the intramolecular 
stacking formation as shown in Figure 4-11. Thus, the non-specific binding of TO unit will 
increase, and lead to the low selectivity of this ligand. 
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4-4-3. A demonstrate application by using let-7 family microRNAs 
    Finally, we apply our Py-PNA-TO ligand into the detection of microRNAs. As 
mentioned in the introduction section, let-7 microRNAs are tumer-related with highly similar 
sequences. The sequences are listed as follows: 
 
let-7a:  5’- UGAGGUAGUAGGUUGUAU AGUU-3’ 
let-7b:  5’- UGAGGUAGUAGGUUGUGUGGUU-3’ 
let-7c:  5’- UGAGGUAGUAGGUUGUAUGGUU-3’ 
let-7f :  5’- UGAGGUAGUAGAUUGUAUAGUU-3’ 
let-7d:  5’- AGAGGUAGUAGGUUGCAUAGU-3’  
let-7e:  5’- UGAGGUAGGAGGUUGUAUAGU-3’  
let-7g:  5’- UGAGGUAGUAGUUUGUACAGU-3’  
let-7i:   5’- UGAGGUAGUAGUUUGUGCUGU-3’ 
DNA probe:   3’-CCATCATCCTTCGTATCA-5’ 
RNA probe:   3’-CCAUCAUCCUUCGUAUCA-5’ 
 
    The 1
st
 terminal nucleobase of let-7d is adenosine (A), while all the others are urine (U). 
Therefore, we chose let-7d as the target and therefore synthesized Pyrene-TCT-C4-TO 
(Py-TCT-TO, Figure 4-12 (A)) for it. Successfully, a clear selectivity for let-7d out of all the 
let-7 sequences was obtained (Figure 4-12 (B)). By taking three times independent 
experiments, a figure with error bars was also obtained, suggesting the experiment result is 
repeatable (Figure 4-12 (C)). Also, by using RNA probe to complementarily form duplexes 
with let-7 microRNAs, can get a similar result (Figure 4-13). 
    It’s exciting that in this demonstration, the very 1st terminal mismatch can be recognized 
with Py-TCT-TO, where is the most difficult to discrimination position. In addition, the 
success also indicates this PNA-TO ligand can be used for not only DNA duplex, but also 
DNA/RNA hybrid, or RNA duplex. 
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Figure 4-12. (A) Structure of Pyrene-T
PNA
-C
PNA
-T
PNA
-(CH2)4-TO (Py-TCT-TO); 
(B) Fluorescence spectra of Py-TCT-TO for let-7d; 
(C) Bar figures of let-7 family microRNAs. 
[let-7 RNA/DNA hybrid] = [Py-CCC-C4TO] = 200 nM, buffer, pH 7.0, 20C, Sensitivity: medium, Ex band: 
3 nm, Em band: 5 nm, 33 quartz cell, Excitation: 514 nm, Analysis at 531 nm. 
 
 
 
 
Figure 4-13. Bar figures of let-7 family microRNAs by using RNA probe. 
[let-7 RNA/RNA duplex] = [Py-CCC-C4TO] = 200 nM. Other solution conditions are the same as given in 
Figure 4-12. 
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Under the present experimental conditions, LOD for let-7d was determined as 18 nM 
(0.9 nmol in 50L sample) according to eq (1) in Chapter 2. As for the response to let-7d, the 
equation obtained by the linear fitting (Figure 4-14) is y = 0.31776 + 0.12697 x (R = 
0.99946). The standard deviation of blank (Sblank) is 0.75403. According to the equation (1), 
LOD was thus estimated as 18 nM, which is comparable with Northern blotting. 
 
 
 
Figure 4-14. The linear fitting analysis for the determination of detection of limit (LOD). 
[let-7 RNA/DNA hybrid] = 0, 10, 20, 50, 100, 200 nM, [Py-CCC-C4TO] = 50 nM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
94 
 
4-5. Conclusion 
    We successfully developed a series of PNA-TO ligands with high selectivity for perfect 
match sequence over terminal mismatched ones, even for a single mismatch at the very 1
st
 
terminal position. It’s effective at both 5’ and 3’ terminals, and introducing pyrene to the 
ligand as a molecular cap has improved the specificity for the 1st terminal position mismatch 
at 5’ end. In addition, it’s applicable to microRNA detection with high selectivity and 
sensitivity. 
Since we used both DNA and RNA strands in our study, the PNA-TO ligands probably 
can be utilized in both DNAs and RNAs and the type of target nucleobases are not limited. 
Furthermore, it’s a method which is real modification-free of DNA/RNAs for SNPs detection 
at terminal positions. 
However, we have to admit the limitations of our method. Such as, the synthesis of 
ligands is a time cost work. And the fluorescence stability of the binding PNA-TO/DNA or 
RNA complex is not that good. After preparation of examples, measurement should be soon 
taken in case of the quenching of fluorescence. 
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Chapter 5: Conclusion 
 In summary, we have developed three systems by utilizing the interactions between small 
ligand and DNA/RNAs. 
 
In chapter 2, we developed an AP site-containing AP-aptamer without modification with 
fluorescent probes. It was based on the competitive binding of theophylline with riboflavin at 
the AP site. In the absence of theophylline, riboflavin binds to the receptor nucleobase 
opposite the AP site, and this is accompanied by fluorescence quenching. Upon addition of 
theophylline, the competitive binding of theophylline with riboflavin occurs, which results in 
the effective fluorescence restoration due to the release of riboflavin from the AP site. 
Fluorescence response showed a good linear correlation to the concentration of 
theophylline ranged from 10 M to 32.5 M in horse serum samples, and little response was 
observed for caffeine and theobromine. Importantly, this range corresponds to the 
concentration range from 50 M to 162.5 M in the original serum samples, which covers the 
therapeutic range (60-100 M).  
Due to the high selectivity for theophylline, the present method could be successfully 
applicable to detect serum theophylline in a therapeutic concentration range. Since neither the 
covalent labeling with signal transduction units nor the modification with the fluorescent 
nucleotide analogues is required, the proposed assay is simpler, easier, and more 
cost-effective than typical assays based on theophylline-binding RNA-aptamers. These 
characteristics of the proposed method are clearly advantageous for practical use.  
 
 
 In chapter 3, we developed a small ligand CF3-AMND for the detection of SNPs. It 
showed increasingly high C/T selectivity as over 50-fold, compared with the parent AMND 
as 4.2-fold.  
    The high selectivity of CF3-AMND might be caused from more favorable protonation at 
the N1 position than the N8 position due to the electron-withdrawing effect of the CF3 group, 
which then enables the effective pseudo-base pairing with C through hydrogen bonding. 
Furthermore, CF3-AMND is applicable to the analysis of single-base mutation in 107-mer 
DNAs (K-ras gene; codon 12, sense strand) amplified by asymmetric PCR, with highly 
selectivity for C. This will facilitate the accurate analysis of C-related single-base mutation in 
practical use. 
 
In chapter 4, we developed a series of PNA-TO ligands for the detection of a single 
terminal mismatches in DNA/RNA sequences. PNA unit recognizes the terminal nucleobases 
and TO unit intercalate into the DNA or RNA duplex and emit a fluorescent signaling. 
effective at both 5’ and 3’ terminals, and introducing pyrene to the ligand as a molecular 
caphas improved the specificity for the 1st terminal position mismatch at 5’. In addition, 
Pyrene-PNA-TO is applicable to microRNA detection to recognize let-7d out of let-7 family 
with LOD as low as 0.9 nmol in 50 L sample. It’s thus expected that our method is 
promising for terminal mismatch detection and the ligand design would have flexibility for 
any kind of terminal sequences. 
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